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ABSTRACT 
In Chapter 1, attempts to reproduce eight, putative, enantioselective dibromination and 
chlorohydroxylation reactions from oft-cited literature studies are described. The reactions were 
performed with full fidelity to the original report wherever possible. Analysis of the enantiomeric 
composition was performed by CSP-HPLC or CSP-SFC, as opposed to the original report, which 
used chiral shift reagent NMR spectroscopy. After careful study, the reported levels of 
enantioselectivity were found to be incorrect. Possible explanations for the false positive results 
are discussed.  
Chapter 2 moves to a completely different area of chemistry, in the Nobel Prizewinning 
field of cross-coupling. A bench-stable, crystalline siloxaborolate is described, capable of double 
cross-coupling reactions to form ortho-teraryls. The initial Suzuki reaction proceeded with high 
yields but the second, Hiyama-Denmark reaction proved troublesome for coupling with electron-
rich aryl bromides, providing only low yields of the desired teraryls. A four-factor DoE study was 
undertaken to attempt to identify conditions to allow a more general scope for teraryl synthesis, 
however, these could not be identified in the study.  
Chapter 3 involves, again, a project very distinct from the other two. This took the form of 
synthesis and validation of a large, multipurpose set of diverse bisoxazolines of computationally-
aided design. This ligand set was tasked with the enantioselective synthesis of C-substituted 
morpholines, for which a general and highly-selective cyclization has not yet been discovered.  
A number of ligands were tested for the cyclization of SnAP imines to this purpose, this being a 
highly general method for morpholine synthesis that previously lacked excellent 
enantioselectivity, and a broad spread of data was achieved for the purposes of computational 
modeling.  
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CHAPTER 1 REINVESTIGATION OF A CATALYTIC, ENANTIOSELECTIVE ALKENE  
DIBROMINATION AND CHLOROHYDROXYLATION†11 
“To kill an error is as good a service as, and sometimes even better than, the  
establishing of a new truth or fact” – Charles Darwin 
1. INTRODUCTION 
The halofunctionalization of alkenes with electrophilic halogenating agents has long been 
a staple of stereoselective synthesis, prized for its predictable constitutional selectivity and relative 
stereochemical course.2–4 However, catalytic dihalogenation methods, in which the absolute 
configuration of the products is controlled from an achiral starting material, have proved elusive 
until recently.5–8 Enantioselective bromination is of particular interest due to the ability of bromide 
to act as a leaving group in stereospecific substitution reactions. Additionally, over 3800 
organobromine compounds are known in nature, the majority isolated from marine organisms.9–11  
In the reactions of olefins with Br2, vicinal dibromides are formed via bromide ion attack on 
either an alkene−Br2 π-complex or a bromiranium ion, resulting in anti-stereospecific addition of 
Br2 across the double bond.
12–14 However, strategies for enantioselectivity may be thwarted in a 
number of ways: (1) A racemic background reaction may occur from the formation of molecular 
bromine (or its equivalent) when both electrophilic and nucleophilic bromine sources are present; 
(2) facial selectivity must also be controlled to produce an enantioenriched alkene-Br2 π-complex 
or bromiranium ion intermediate; (3) bromiranium ions are configurationally unstable in the 
presence of excess olefin, via an alkene-to-alkene transfer pathway;15 and (4) the regioselectivity 
of bromide addition must also be controlled, since attack on either carbon atom of a non-C2-
symmetric bromiranium ion intermediate yields enantiomeric products (Scheme 1).  
                                                                
† Results and conclusions of this chapter are outlined in a report published in Organic Letters.1 © American Chemical 
Society; adaptation and redistribution allowed by an ACS AuthorChoice license for non-commercial purposes.  
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Scheme 1. Addition of Bromine Equivalents to Alkenes 
 
2. BACKGROUND 
Despite the extensive history of dihalogenation and other halofunctionalization reactions 
of alkenes, methods to form stereodefined, dihalogenated products from olefins are rare. Chiral, 
enantiopure chloro- and iodosulfonium reagents have been used to effect the enantioselective anti-
dichlorination and interhalogenation of 1,2-dihydronaphthalene 1, albeit with compromise 
between moderate enantiomeric ratio and low yield (Scheme 2).16 In the case of the dichlorination, 
the chlorosulfonium reagent was generated in situ from chiral sulfide 2 and SbCl5. 
Bromochlorination proved unsuccessful, the bromochloride 4 apparently being unstable, and close 
to racemic. Chloroiodination was also attempted, but the product was unstable on silica gel, 
resulting in several decomposition products. When the chloroiodination reaction was quenched 
with H2O, anti-iodohydrin 5 was formed in 25% yield and 74.5:25.5 er.  
Scheme 2. Enantioselective Anti-Dihalogenation of 1,2-Dihydronaphthalene 
 
The same group also employed an enantioselective dichlorination in the total synthesis of 
the estrogen antagonist (−)-napyradiomycin A1 (Scheme 3).17 Enantioselectivity was controlled 
by a large excess of axially chiral diol additive 7, apparently by π-stacking with the substrate. The 
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stereochemistry of the C–Cl bond that does not appear in the natural product was exploited by a 
regioselective, retentive substitution by acetate in the following step.  
Scheme 3. Enantioselective Dichlorination in the Total Synthesis of (−)-Napyradiomycin A1 
 
In 2011, Nicolaou and coworkers reported an anti-dichlorination reaction of cinnamyl 
alcohols 8 using (DHQ)2PHAL as the catalyst and an aryl dichloroiodane as the chlorinating agent 
(Scheme 4).18 Dichloride products 9 were formed from electronically-diverse cinnamyl alcohols, 
in a wide range of selectivities (62.5:37.5–90.5:9.5 er). Monobenzylated (E)- and (Z)-but-2-ene-
1,4-diol were also viable substrates, although the dichlorinated products were obtained in only 
71.5:28.5 and 77:23 er, respectively. 
Scheme 4. Enantioselective Anti-Dichlorination of Allylic Alcohols 
 
More recently, Burns and coworkers developed an enantioselective dibromination of 
cinnamyl alcohols 8 using dibromomalonate 10 as an electrophilic bromine source and  
BrTi(Oi-Pr)3 as a nucleophilic bromine source, with TADDOL-derived catalyst 11 (Scheme 5).
19 
The dibromide products 12 were formed with good enantioselectivities (85.5:14.5−92.5:7.5 er). 
This work was later extended to enantioselective bromochlorination of allylic alcohols with 
constitutional site selectivities of 6:1−>20:1 and enantioselectivities of 89:11− 98.5:1.5 er.20  
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Scheme 5. Anti-Dibromination of Allylic Alcohols 
 
Most recently, allylic alcohols 13 have also been used as substrates for enantioselective 
anti-dihalogenation, without the need for aryl groups enforcing regioselective attack on a benzylic 
haliranium intermediate (Scheme 6).21 In the case of dibromination, NBS and BrTi(Oi-Pr)3 were 
used as bromine sources, and enantiomeric ratios of 90:10–93.5:6.5 were obtained. For 
dichlorination, t-BuOCl and ClTi(Oi-Pr)3 afforded enantiomeric ratios of 90.5:9.5–95.5:4.5. Imino 
diol 14 was used in both cases as chiral catalyst. However, neither protocol has yet been shown to 
be compatible with any heteroatomic functionality. Burns was also able to apply the 
enantioselective dichlorination methodology to the syntheses of the unnatural enantiomers of 
natural polychlorosulfolipids danicalipin A and deschloromytilipin A, the rest of the stereodefined 
chlorine atoms being installed via diastereoselective reactions (Scheme 7).  
Scheme 6. Enantioselective Dihalogenation of Allylic Alcohols 
 
Scheme 7. Synthesis of (−)-Danicalipin A and (−)-Deschloromytilipin A from a Common Motif 
 
The proposed catalytic cycle throughout Burns’s work involves a haliranium ion I that may 
be captured quickly by intramolecular halide delivery from the coordination sphere of Ti (Scheme 
8). This process avoids both a racemic background reaction and the rapid racemization of 
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enantioenriched bromiranium (and by extension, chloriranium) ions in the presence of free alkene. 
Despite its high reactivity leading to a facile background reaction, t-BuOCl gave the highest 
selectivities in a screen of multiple electrophilic chlorine sources, possibly due to its Lewis basic 
nature allowing it to bind to the chiral Ti adduct.  
Scheme 8. Burns’s Proposed Dihalogenation Catalytic Cycle using Diol Ligands. Adapted with permission from  
J. Am. Chem. Soc., 2013, 135, 12960–12963, © 2013 American Chemical Society 
 
The Wacker oxidation has also been modified for halofunctionalization of alkenes. The use 
of high chloride ion concentrations under Wacker-type conditions results in the conversion of 
ethylene to ethylene chlorohydrin, instead of the expected acetaldehyde product.22 An 
enantioselective variant of this reaction was subsequently reported by Henry and coworkers, using 
chiral, nonracemic palladium(II) bisphosphine catalysts 15 to achieve the enantioselective 
generation of chlorohydrins 16 from terminal alkenes 17 (Scheme 9).23 The possibility of a facile 
background reaction stemming from dihalogen formation was reduced by the use of chloride as 
the sole halogen source. A limited number of chlorohydrins were produced, with constitutional 
site selectivities of 5.5:1−>95:1, and reported enantioselectivities of 64:36−91:9 er (Scheme 9a). 
In all cases, yields were reported based solely on O2 uptake.  
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Scheme 9. Henry’s Wacker-type Chlorohydrin Synthesis 
 
Enantioselectivity was reportedly improved in later work by Henry and co-workers, by the 
use of dinuclear palladium(II) complexes 18 with bridging triketone ligands, although no direct 
comparisons to the mononuclear catalysts were made (Scheme 9b).24–26 Terminal olefins 17 were 
converted to chlorohydrins 16 with constitutional site selectivities of 2.3:1−>95:1 and 
enantioselectivities of 57.5:42.5−97:3 er.  
Henry and co-workers later reported an extension of this work to the enantioselective 
dibromination of olefins, using similar Wacker-type conditions with 2.5−17.7 mol % (per Pd atom) 
palladium(II) catalyst 15 or 18 (Table 1).27 The reactions were performed in aqueous THF 
solutions of varying composition, containing copper(II) bromide (∼2 M) and lithium bromide 
(0.13−0.29 M). The concentration of alkene substrate 19 varied between 0.06 and 0.47 M. Since 
these reaction conditions (i.e., concentrations of LiBr, CuBr2, catalyst, and alkene, and solvent 
THF/H2O ratio) varied incoherently for each substrate, attempt at direct comparison is of limited 
value. The higher intrinsic nucleophilicity of bromide ion compared to H2O, coupled with the high 
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bromide ion concentrations employed, led to the formation of vicinal dibromides 20 rather than 
bromohydrins as the major products. Yields of dibromides reported were highly variable 
(31−95%), and one was indecipherable – a yield of 80%, based on O2 uptake, is reported for the 
dibromination of methyl crotonate, but 30% of the starting material was also recovered (Table 1, 
entry 6).  Good to excellent enantioselectivities were claimed (90:10−98.5:1.5 er), apart from the 
case of methyl (E)-cinnamate (Table 1, entry 9; 57:43 er). Enantiomeric ratios were determined by 
1H NMR spectroscopic analysis using chiral shift reagent Eu(hfc)3, although neither spectra nor 
details of concentrations were given. Optical rotation data were provided for only two of the nine 
dibromide products.  
Henry and coworkers claimed the rate does not decrease during the reaction, i.e. it was 
overall zeroth order. Qaseer, a coauthor on the original dibromination paper, later reported a 
similar system using Wacker-type conditions and a racemic dinuclear PdII catalyst 18a to generate 
vicinal dibromides, and reported a zeroth order rate of O2 uptake (Scheme 10).
28 However, 
measurement of O2 uptake is insufficient to substantiate claims related to the rate of product 
formation. For example, the yield for the dibromination of methyl crotonate (catalysed by a 
mononuclear palladium(II) bisoxazoline complex) is reported as 80% based on O2 uptake. 
However, the amount of recovered starting material is 30% by mass. This inconsistency 
exemplifies that O2 uptake is not a reliable method for monitoring product formation.  
Scheme 10. Qaseer’s Racemic Alkene Dibromination 
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Table 1. Henry’s Reported Enantioselective Dibromination Results 
 
Entry  Producta Nuclearity 
of catalyst 
Ligand Recovered 
alkene 
Dibromide 
yield, %b 
erc 
1  
 
Ambiguous 
in original 
text 
(S)-BINAP NR 95 98:2 
2  
 
2 (S)-Tol-BINAP NR 95 98.5:1.5 
3  
 
2 (S)-BINAP NR 95 97.5:2.5 
4  
 
1 (S)-BINAP NR 95 97:3 
5  
 
2 (S)-METBOX 63% 31 97:3 
6  
 
1 (S)-BZOX 30% 80d 92:8 
7  
 
2 (S)-METBOX 21% 70 91:9 
8  
 
2 (R)-BINAM 24% 77 90:10 
9  
 
2 (R)-BINAM 12% 83 57:43 
10  
 
2 (S)-Tol-BINAP NR 85e - 
NR = not reported. a Absolute configuration not determined. b Isolated yield. Yields differ from the values in the 
original paper since they are based on olefin substrate rather than recovered starting material, where this information 
is available. c er of dibromide products determined by 1H chiral shift reagent NMR. d Yield calculated from oxygen 
uptake. e An unnamed side-product was formed in approximately 14% yield by GC analysis. 
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3. RESULTS 
3.1 Enantioselective Dibromination of Alkenes 
Four reactions in the original report from Henry and coworkers (Table 2, entries 1−7) were 
replicated. The allylic ether dibromination procedures were repeated as rigorously as the described 
procedures allow, albeit on a smaller scale (0.25 mmol versus 2.8−3.7 mmol allylic ether in the 
original work). To confirm that scale was not a critical factor, one trial was performed on the 
original scale (3.0 mmol) and was let run for the original reaction time of 6 days (Table 2,  
entry 3). Although dibromides 20 revert to the corresponding allylic ethers 19a–d over several 
weeks in light, running reactions and isolating products in the dark affected neither the yields nor 
enantioenrichment of products. Workup and chromatographic isolation of products was performed 
immediately and identically to the original protocol to obviate any possibility of epimerization 
over time.  
The catalyst used in Table 2, entry 1 was produced by replication of Henry’s described 
method with as complete fidelity as possible. This procedure afforded a mixture of compounds, as 
determined by 31P NMR spectroscopy. The dinuclear palladium complexes used in Table 2, entries 
2, 5, and 6 were synthesized by a modification of Henry’s method, in which NaH rather than Et3N 
was used as a Brønsted base. Although in one procedure, the authors describe the addition of 
Me3N, it appears Et3N was actually used.
24,25 This procedure afforded compounds that appeared 
to be pure by 31P NMR spectroscopy and circumvented the laborious separation of 
triethylammonium tetrafluoroborate from the complex. The pure complexes were stored in a 
glovebox and were found to decompose over time in solution, and in vacuo, with decomposition 
observable by NMR spectroscopy after just a few minutes in vacuo. It is likely that vacuum 
promotes loss of the labile MeCN ligands. The complexes were therefore characterized and used 
immediately after purification. The decomposition product (readily visible as a multiplet 
exhibiting P-P coupling by 31P NMR spectroscopy) could be removed by extensive washing of the 
solid with anhydrous, degassed toluene under an Ar atmosphere. Nonetheless, the method of 
preparation of the dinuclear complex had no impact on the reaction outcome (Table 2, entries 1−2). 
For operational simplicity, the mononuclear PdII bisphosphine complexes 15 used in entries 3−4 
were generated in situ from Pd(MeCN)4(BF4)2 and the requisite chiral bisphosphine.
29 The 
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mononuclear catalyst used in Table 2, entry 7 was prepared under Ar and found to be stable in the 
absence of air and moisture.30 All reactions were run under positive pressure from an O2 manifold.  
Moderate to high yields of dibrominated products 20 were obtained, with small amounts 
of side products observable in the 1H NMR spectra. Both the crude product mixtures and the 
chromatographically pure dibromides were analysed by CSP-HPLC or CSP-SFC to assess 
enantioenrichment. In every case examined, the vicinal dibromides were racemic (Table 2). It is 
notable that, in our hands, the complete conversion of starting material was achieved in 
significantly shorter times than those quoted in the original work: 24 or 28 h versus 4−7 days. It is 
possible that the original reactions were monitored by O2 uptake whereas our experiments were 
monitored by TLC conversion. A repeat of the dibromination of allyl 4-methoxyphenyl ether 19a 
was arbitrarily stopped after 6 h (Table 2, entry 4) to determine whether an initial enantioselective 
process may occur, only to be compromised by epimerization under the reaction conditions. In this 
case as well the product was racemic.  
In light of these results, four chlorohydroxylation reactions from Henry and co-workers’ 
earlier reports were also investigated (Table 2, entries 8−11).23 These experiments were performed 
on a 0.5−1.0 mmol scale (original scale: 3.7−6.5 mmol where reported). However, analysis by 
CSP-SFC and CSP-GC again revealed that all chlorohydrin products 16 were racemic.  
In their original report, Henry and coworkers proposed a mechanism that bypasses a 
bromiranium ion intermediate, instead suggesting that the palladium complex (shown as 
mononuclear with a chiral ligand abbreviated as L) coordinates olefin 19 (Scheme 11). Free 
bromide then attacks the activated olefin II from the opposite face, yielding an alkylpalladium(II) 
complex III. CuII may stereoretentively oxidize the C−PdII bond to form the alkyl bromide without 
overall oxidation state change at Pd.31 This putative bromide may be derived from either the 
coordination sphere of Pd or that of Cu in complex II.  
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Table 2. Comparison of Results for the Dibromination and Chlorohydroxylation of Several Substrates 
Run Ligand Nuclearity 
of complex 
Time, 
days 
Product Yield, 
% 
er Lit. 
yield,  
% 
Lit. er 
1 (R)-BINAPa,e 2b 1.17 
 
86d 50:50 95 98:2 
2 (R)-BINAPa 2b 1.17 
 
86d 50:50 95 98:2 
3 (R)-BINAPa 1b 6 
 
78c 50:50 95 98:2 
4 (R)-BINAPa 1b 0.25 
 
65d 50:50 - - 
5 (R)-Tol-BINAPa 2 1 
 
85d 50:50 95 98.5:1.5 
6 (R)-BINAPa 2 1 
 
69d 50:50 95 97.5:2.5 
7 (R)-BINAPa 1 1 
 
90d 50:50 95 97:3 
8 (R)-Tol-BINAP 1 14 
 
14 50:50 NR 90:10 
9 (R)-BINAPa,e 2 5 
 
40 50:50 92 96.5:3.5 
10 (R)-Tol-BINAP 1 10 
 
33f 50:50 NR 91:9 
11 (R)-BINAPa,e 2 10 
 
29 50:50 95g 90:10 
NR = not reported. a The (S)-enantiomer of the ligands was used in the original work. b The nuclearity of the catalyst 
used is ambiguous in the original text. c 3.0 mmol scale. d The yield is the average of two runs, each within 2% of the 
average. e The dinuclear catalyst was produced exactly according to Henry’s procedure. f 1.0 mmol scale. g The product 
was mischaracterized in the original work.   
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Scheme 11. Putative Catalytic Cycle for Dibromide Formation 
 
No side-products were reported in many reactions; others contained a small amount of 
undesired bromohydrin. Qaseer’s later report claims 10–25% ketone and/or bromohydrin side-
products are present in all crude reaction mixtures.14 In our hands, tiny amounts of organic side-
products were observable by 1H NMR in all reactions.  
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4. DISCUSSION 
The ability to reproduce the formation of the dibromides 20 and chlorohydrins 16 from 
multiple substrates following the original procedure, but to obtain uniformly racemic products, 
presents a quandary. The possibility that important details are missing for preparing the catalysts 
or executing the reactions cannot be excluded. Certainly many possibilities exist for generating 
Br2 under the reaction conditions, and indeed, CuBr2 itself is also capable of effecting the 
dibromination of alkenes at room temperature.32,33 However, in our opinion, the more likely 
explanation for the disparity is the authors’ use of chiral shift reagent NMR analysis to determine 
the enantiomeric composition of the dibromide products. Unfortunately, the spectral data are not 
provided. Our own attempt to observe signal separation in a racemic sample of  
allyl 4-methoxyphenyl ether 19a using Eu(hfc)3 was inconclusive. After portionwise addition of  
4 equiv of the chiral shift reagent, some degree of signal separation was observed, showing roughly 
equal quantities of each enantiomer. However, the level of signal broadening precluded any 
quantitative determination of enantiomeric ratio.  
5. CONCLUSIONS 
In conclusion, four dibromination and four chlorohydroxylation reactions of allylic ethers 
catalysed by chiral mono- or dinuclear palladium(II) complexes reported by Henry and coworkers 
were repeated. Although the reaction yields were reproduced, the dibromide and chlorohydrin 
products were generated in racemic form.  
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CHAPTER 2 DOUBLE CROSS-COUPLING REACTIONS OF SILOXABOROLATES 
1. INTRODUCTION 
Palladium-catalysed cross-coupling is a pillar of organic synthesis, ubiquitous in industrial 
and academic settings, for synthetic and medicinal chemistry, and materials applications. This 
versatile, Nobel Prizewinning method is most prevalently used to forge sp2-sp2 bonds, to make flat 
moieties commonly found in drug molecules.34–37  
Recently, a stable, crystalline siloxaborolate has been developed in these laboratories. This 
dual-functionalized molecule is firstly reactive in Suzuki couplings with a range of organohalides 
to yield an ortho-substituted arylsilanol after aqueous workup, which may then be deprotonated to 
an arylsilanolate (Scheme 12). This anionic species is then primed for a Hiyama-Denmark cross-
coupling, which permits the use of inexpensive, non-toxic silicon reagents in bond formation 
without need for an external activator.   
Scheme 12. Formation of Teraryls by Double Cross-Coupling from Siloxaborolate 24 
 
This double, sequential C–C bond formation could allow a wide variety of ortho-teraryls 
21 and other ortho-disubstituted arenes. Other siloxaborolates could potentially be developed to 
further expand this process to the synthesis of, for example, further substituted arenes, vicinally-
disubstituted unsaturated heterocycles, or (Z)-disubstituted alkenes from siloxaborates 25–27, 
respectively (Scheme 13).  
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Scheme 13. Double Cross-Coupling Reactions of Other Siloxaborates 
 
Additionally, since the immediate product of the initial Suzuki reaction prior to workup in 
a silanolate, the double coupling process could potentially be improved to a one-pot procedure 
without isolation and separate deprotonation of the monocoupled silanol.  
2. BACKGROUND 
 The Suzuki cross-coupling between arylboron species and aryl halides or triflates is one of 
the most widely-developed cross-coupling methods.38–44 The range of functional group 
compatibility is very high, and boron byproducts are readily removed during workup procedures. 
Boronic acids remain the most popular boron reagents, although their use may result in 
protiodeborated or homocoupled side-products during the coupling process.45,46 Additionally, 
many boronic acids are prone to dehydrative trimerization to boroxines, resulting in their use in 
excess due to uncertainties in stoichiometry. This problem may be resolved by using boronate 
esters, although their use can complicate purification steps. To mitigate these concerns, 
aryltrifluoroborate salts are increasing in usage. These are generally indefinitely air- and water-
stable, readily-prepared, and often commercially-available.46–51 The inorganic borate side-
products are readily separated from the desired products. Importantly, protiodeboration is inhibited 
in these systems.  
 Cross-coupling of easily-accessible silanol and silanolate donors (the Hiyama-Denmark 
reaction) is a versatile method, offering a wide range of functional group compatibility.52 
Organosilanols are air- and moisture-stable, and readily-synthesized via diverse methods. These 
features particularly stand out in contrast to organosilanes, the first Si cross-coupling reagents to 
16 
 
 
be used (the Hiyama reaction), in addition to their ability to avoid fluoride activation of the 
silane.53–57 Thus far, (hetero)aryl-,58–60 alkenyl-,61–64 and allylsilanolates65–67 have been used as 
coupling donors. The dominant transmetalation pathway in these systems is by silanolate 
assistance, where a second silanolate molecule is required to activate the Si atom in the Si–O–Pd 
linkage of the pre-transmetalation intermediate.  
 Sequential, double cross-coupling methods are known, typically by use of a 
homobifunctional dielectrophile or organodimetallic reagent that may be selected for in turn either 
by intrinsic selectivity differences or by iterative coupling of symmetrical substrates, exploiting 
reactivity differences between the starting material and monocoupled product (Scheme 14a).68–71 
Substrates containing two functional groups of differing reactivity (eg: 1-chloro-2-iodobenzene 
and its derivatives allow the generation of products with unsymmetrical substitution on the initial 
coupling partner (Scheme 14b)).72–75 Likewise, one functional group may be masked initially, and 
unmasked for a second coupling (Scheme 14c).76–78 Lastly, functionalized organometallics may be 
used firstly as cross-coupling donors and then as electrophiles in a second cross-coupling reaction, 
so long as homocoupling is minimal (Scheme 14d).79–81 These strategies allow selectivity of mono- 
over dicoupled products in the initial step, leaving a single functional handle for a second reaction 
with a different coupling partner.  
Scheme 14. Double Suzuki Cross-Coupling Strategies to form Ortho-Disubstituted Arenes 
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 Alternative strategies for the formation of teraryls or other ortho-diorganyl arenes include 
(directed) C–H activation strategies,82,83 or cyclization to form one or more arene rings.84  
3. RESEARCH OBJECTIVES 
 The object of this project was to effect double cross-coupling from siloxaborolate 24. 
Firstly, a Suzuki coupling is performed. Although the immediate product of this reaction is the 
respective silanolate, aqueous workup and isolation of the silanol will be performed, followed by 
its deprotonation to the silanolate. This allows pure silanolate to be used for the initial screening. 
The Hiyama-Denmark coupling will then be performed. Yields of both cross-couplings will be 
optimized, with a view to creating a general procedure for the synthesis of many 1,2-disubstituted 
compounds, including ortho-teraryls 21.  
4. SYNTHETIC STRATEGIES 
Siloxaborolate 24 was synthesized in four steps from 1,2-dibromobenzene 28 (Scheme 3). 
Firstly, a Knochel Grignard lithium-bromine exchange generated the aryl Grignard reagent in situ, 
with subsequent displacement of chloride from chlorodimethylsilane to form aryl silane 29. This 
silane was oxidized using H2O with 1 mol % [Ir(cod)Cl]2 to form silanol 30, which may then be 
deprotonated, lithiated and borylated to siloxaborolol 31. Treatment of this boronate semiester with 
potassium bifluoride in aqueous methanol yielded 24 in 62% yield.  
Scheme 15. Synthesis of Siloxaborolate 24. cod = 1,5-cyclooctadiene 
 
Siloxaborolate 24 can undergo Suzuki reactions with aryl bromides via the borate 
functional group to yield 2-biphenylsilanol derivatives 23 (Scheme 4). The products can then be 
deprotonated with potassium hydride to form potassium 2-biarylsilanolates 22, which may 
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undergo a Hiyama-Denmark reaction with an aryl bromide via the silanolate functional group to 
yield the desired ortho-terphenyl product 21.  
Scheme 16. Iterative Suzuki and Hiyama-Denmark Cross-Coupling Reactions of Siloxaborolate 24 
 
 
5. INITIAL STUDIES 
Early work on this project was performed by Dr Brian Casey. (2-Biphenyl)dimethylsilanol 
23a could be formed from bromobenzene in 74% yield and deprotonated with KH to  
silanolate 22a (Scheme 17a). This silanolate was used as a test substrate for optimization of the 
Hiyama-Denmark coupling step. Initial studies showed that using [AllylPdCl]2 as the palladium 
source in the absence of external ligands at 100 °C, teraryl 21a could be formed in 96% yield after 
4 h from 4-bromobenzotrifluoride (Scheme 17b). However, reaction under the same conditions 
with electron-rich anisoyl bromide produced teraryl 21b in only 44% yield after 16 h  
(Scheme 17c).  
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Scheme 17. Initial Studies of the Hiyama-Denmark Reaction with Electron-Deficient and Electron-Rich Aryl 
Bromides 
 
Since coupling of electron-rich aryl bromides to the hindered ortho-substituted biphenyl 
silanolate proved troublesome, a Design of Experiment (DoE) study was planned, based on factors 
(aka: variables) of solvent, temperature, ligand, and palladium source. This was designed to allow 
rapid optimization of conditions for the Hiyama-Denmark cross-coupling.  
It was hypothesized that oxidative addition of the aryl bromide to the palladium center, 
being more difficult for electron-rich aryl groups, is the limiting step for this reaction. Strategies 
to counter slow oxidative addition have historically included the use of strongly σ-donating 
ligands, particularly phosphines, and the use of bulky ligands to favor ligation of only one 
phosphine ligand to Pd.85 However, all external ligands tested within these laboratories thus far 
show less reactivity than allylpalladium(II) chloride dimer alone.86 This may be an indication of 
the necessity of sterically unencumbered ligands to facilitate transmetalation. These competing 
effects imply that an electron-rich ligand with intermediate steric bulk may be ideal to achieve 
high yields. XPhos L11 (Chart 1) and other 2-biphenylphosphine derivatives have been found to 
be effective for Suzuki couplings of bulky, electron-rich aryl chlorides, which are also known to 
have a low aptitude for oxidative addition.87  
These features informed the choice of levels (predefined values for each factor), with a  
D-optimal design involving 98 reactions to explore the chemical space in the four factors  
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(Chart 1). Each reaction was run for 16 h. A range of temperatures from 80–140 °C was explored, 
along with solvent selections of DME, 1,4-dioxane, toluene, and p-cymene. Combinations of 
solvents and temperature which would raise the solvent above its standard boiling point were 
discarded from the experimental design. Palladium sources employed, in 5 mol % per Pd atom, 
were Pd2(dba)3, allylpalladium(II) chloride dimer, palladium(II) acetate, and 
bisbenzonitrilepalladium(II) chloride. Eleven structurally- and functionally-diverse ligands were 
also entered into the screen.  
Chart 1. Factor levels for DoE study 
 
Solvents 
DME 1,4-dioxane Toluene p-Cymene 
Pd sources 
Pd2(dba)3 [allylPdCl]2 Pd(OAc)2 (PhCN)2PdCl2 
Ligands 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
L1 L2 L3 
(dppf) 
L4 L5 L6 
(dppb) 
 
 
 
 
 
 
 
 
 
 
 
L7 
(DPEPhos) 
L8 L9 
(BINAP) 
L10 L11 
(XPhos) 
L12 
(Xantphos) 
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6. RESULTS AND DISCUSSION 
Each DoE screening reaction was run for 16 h, then immediately worked up. n-Tetradecane 
(100 μmol) was added to each reaction as an internal standard, to allow calculation of yields of 
product and recovered starting materials (anisoyl bromide, and (2-biphenyl)dimethylsilanol 23a, 
produced from the silanolate during aqueous workup). Since protiodesilylation of silanolates 
during cross-coupling is known, yields of biphenyl were also calculated. The results of the DoE 
screen are shown in Table 3.  
No DoE screen reaction could significantly outperform the results obtained with 
‘ligandless’ APC. It appears that the hindered steric environment around Si disfavors the approach 
of a second silanolate to activate the species for transmetalation, allowing side-reactions such as 
protiodesilylation to occur.  
Although this second, Hiyama-Denmark reaction proceeded favorably for electron-poor 
aryl bromides, it remains a challenging procedure for electron-rich aryl bromides such as anisoyl 
bromide.  
Table 3. Results of DoE Screen 
 
Run Solvent Temp,  
°C 
Pd source Ligand Recovered  
ArylBr 
Biphenyl 
yield 
Recovered 
silanol 
Yield 
1 cymene 100 (PhCN)2PdCl2 Xantphos 55% 28% 0% 3% 
2 dioxane 100 [AllylPdCl]2 n-Bu3P 37% 10% 7% 0% 
3 toluene 80 Pd(OAc)2 Xantphos 68% 20% 2% 2% 
4 cymene 80 [AllylPdCl]2 BINAP 48% 14% 2% 4% 
5 dioxane 100 Pd(OAc)2 PPh3 37% n.d. 0% 4% 
6 toluene 80 Pd2(dba)3 AsPh3 39% 2% 31% 0% 
7 cymene 100 Pd2(dba)3 PPh3 9% 8% 1% 1% 
8 cymene 140 Pd(OAc)2 XPhos n.d. 37% 0% 4% 
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Table 3 (cont.). Results of DoE Screen 
Run Solvent Temp,  
°C 
Pd source Ligand Recovered  
ArylBr 
Biphenyl 
yield 
Recovered 
silanol 
Yield 
9 DME 80 Pd(OAc)2 AsPh3 8% n.d. 0% 16 % 
11 DME 80 [AllylPdCl]2 dppb 0% 9% 21% 0% 
12 toluene 100 Pd(OAc)2 bis-hydrazone 68% 16% 3% 8% 
13 cymene 80 [AllylPdCl]2 AsPh3 64% 10% 6% 11% 
14 cymene 100 Pd(OAc)2 n-Bu3P 37% 7% 0% 13% 
15 DME 80 Pd2(dba)3 dppf 0% n.d. 0% 2% 
16 dioxane 80 Pd(OAc)2 BINAP 70% n.d. 3% 3% 
17 cymene 100 [AllylPdCl]2 POPh3 18% 10% 11% 22% 
18 cymene 140 Pd(OAc)2 n-BuPAd2 72% 15% 0% 7% 
19 toluene 100 Pd2(dba)3 dppb 65% 26% 1% 2% 
20 DME 80 (PhCN)2PdCl2 Xantphos 75% n.d. 0% 0% 
21 dioxane 100 Pd(OAc)2 XPhos 25% n.d. 0% 3% 
22 DME 80 Pd2(dba)3 BINAP 0% 24% 0% 4% 
23 toluene 80 Pd(OAc)2 dppf 41% 21% 0% 20% 
24 cymene 100 Pd2(dba)3 dppf 0% 6% 3% 5% 
26 cymene 100 (PhCN)2PdCl2 n-BuPAd2 15% 3% 9% 7% 
27 dioxane 100 (PhCN)2PdCl2 POPh3 81% n.d. 0% 0% 
28 toluene 80 [AllylPdCl]2 bis-hydrazone 10% 0% 5% 45% 
29 dioxane 80 Pd2(dba)3 dppb n.d. n.d. 0% 0% 
30 toluene 80 Pd2(dba)3 POPh3 n.d. 3% 76% 1% 
31 dioxane 100 Pd2(dba)3 Xantphos 54% 34% 2% 0% 
32 dioxane 80 Pd(OAc)2 DPEPhos n.d. 34% 1% 0% 
33 cymene 140 (PhCN)2PdCl2 bis-hydrazone 0% 13% 0% 0% 
34 toluene 100 Pd(OAc)2 POPh3 0% 10% 0% 13% 
37 DME 80 [AllylPdCl]2 POPh3 0% 45% 0% 0% 
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Table 3 (cont.). Results of DoE Screen 
Run Solvent Temp,  
°C 
Pd source Ligand Recovered 
ArylBr 
Biphenyl 
yield 
Recovered 
silanol 
Yield 
39 toluene 80 Pd(OAc)2 XPhos n.d. 5% 62% 2% 
40 cymene 80 Pd(OAc)2 bis-hydrazone n.d. 6% 26% 2% 
42 cymene 140 Pd(OAc)2 PPh3 72% 10% 1% 9% 
43 DME 80 Pd2(dba)3 DPEPhos 83% n.d. 3% 2% 
44 cymene 80 (PhCN)2PdCl2 PPh3 77% 8% 12% 0% 
45 dioxane 100 Pd(OAc)2 n-BuPAd2 0% 51% 0% 4% 
46 dioxane 100 Pd(OAc)2 dppf 44% n.d. 0% 12% 
47 toluene 100 [AllylPdCl]2 AsPh3 0% 4% 7% 49% 
48 cymene 80 [AllylPdCl]2 DPEPhos 38% 19% 10% 1% 
49 toluene 100 [AllylPdCl]2 Xantphos 0% 6% 1% 22% 
51 dioxane 80 (PhCN)2PdCl2 n-Bu3P 44% n.d. 8% 1% 
52 dioxane 100 Pd2(dba)3 AsPh3 79% n.d. 4% 1% 
53 cymene 80 Pd2(dba)3 n-Bu3P n.d. 13% 55% 0% 
54 cymene 80 (PhCN)2PdCl2 dppb 74% 13% 13% 0% 
55 toluene 80 (PhCN)2PdCl2 DPEPhos n.d. 6% 66% 1% 
56 toluene 80 (PhCN)2PdCl2 BINAP n.d. 13% 50% 0% 
57 cymene 80 [AllylPdCl]2 XPhos 54% 18% 1% 6% 
61 cymene 80 Pd(OAc)2 POPh3 84% 7% n.d. 3% 
62 dioxane 100 Pd2(dba)3 BINAP n.d. 84% 0% 0% 
63 dioxane 80 Pd2(dba)3 bis-hydrazone 70% n.d. 7% 3% 
67 DME 80 (PhCN)2PdCl2 bis-hydrazone 0% 96% 0% 0% 
68 toluene 80 Pd(OAc)2 dppb n.d. 14% 32% 3% 
69 DME 80 Pd(OAc)2 PPh3 n.d. 91% 0% 0% 
70 dioxane 80 [AllylPdCl]2 Xantphos 0% 13% 2% 6% 
72 cymene 80 Pd2(dba)3 Xantphos 49% 17% 7% 0% 
24 
 
 
Table 3 (cont.). Results of DoE Screen 
Run Solvent Temp,  
°C 
Pd source Ligand Recovered 
ArylBr 
Biphenyl 
yield 
Recovered 
silanol 
Yield 
73 cymene 100 Pd(OAc)2 AsPh3 58% 6% 1% 3% 
74 toluene 100 (PhCN)2PdCl2 XPhos 56% 5% 36% 4% 
75 toluene 100 Pd(OAc)2 BINAP 0% 5% 2% 33% 
76 cymene 100 (PhCN)2PdCl2 DPEPhos 72% n.d. 0% 0% 
78 toluene 80 Pd(OAc)2 n-BuPAd2 73% 3% 15% 4% 
79 dioxane 80 (PhCN)2PdCl2 AsPh3 n.d. 55% 25% 2% 
80 dioxane 80 [AllylPdCl]2 dppf 0% 17% 2% 22% 
82 cymene 100 [AllylPdCl]2 bis-hydrazone 61% 0% 18% 10% 
83 toluene 100 [AllylPdCl]2 dppf 0% 0% 4% 32% 
84 dioxane 100 [AllylPdCl]2 DPEPhos 7% 4% 3% 26% 
85 dioxane 100 (PhCN)2PdCl2 dppb 100% 0% 0% 0% 
88 cymene 140 Pd(OAc)2 dppf 71% 7% 9% 2% 
90 cymene 80 Pd2(dba)3 n-BuPAd2 43% 11% 5% 4% 
91 dioxane 80 Pd2(dba)3 PPh3 50% n.d. 8% 3% 
94 dioxane 100 (PhCN)2PdCl2 bis-hydrazone 50% 42% 0% 0% 
95 cymene 100 [AllylPdCl]2 dppb 0% 15% 1% 15% 
96 toluene 80 [AllylPdCl]2 PPh3 21% 13% 0% 20% 
97 cymene 80 (PhCN)2PdCl2 dppf 74% 14% 1% 1% 
bis-Hydrazone = L5. n.d. = not determined due to overlap on chromatogram. Run numbers refer to randomization 
numbers generated by the DoE software. Not all integers from 1–98 are represented due to incompatibility between 
solvent and temperature at standard pressure.  
 
7. FUTURE WORK 
It is possible that combinations of temperature, solvent, Pd source, and ligand are not 
sufficient to raise the yields of this reaction with electron-rich aryl bromides to synthetically useful 
standards. It appears that the low reactivity is a result of steric obstruction around the Si atom. Use 
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of cesium rather than potassium silanolates may favor transmetalation, due to their higher 
nucleophilicity.  
If it is possible to increase the yields to a useful level, other analogs of 24 may be produced, 
to yield other 1,2-disubstituted products, including 1,2-disubstituted heterocycles, or (Z)-alkenes.  
The immediate product of the initial Suzuki reaction prior to workup is a silanolate. 
Therefore, the optimized double cross-coupling reaction could potentially be expanded to a  
one-pot process without the requirement of isolation and separate deprotonation of the 
monocoupled silanol.  
8. CONCLUSIONS 
A bench-stable, crystalline oxasilaborolate capable of double cross-coupling reactions to 
form ortho-terphenyls has been synthesized. The initial Suzuki reaction gave high yields. 
However, after a four-factor DoE study, conditions were not identified to allow synthetically useful 
Hiyama-Denmark couplings of electron-rich aryl bromides, and the project was not continued. 
This contrasts with electron-poor aryl bromides, which could be coupled in excellent yield.  
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CHAPTER 3 THE ENANTIOSELECTIVE SYNTHESIS OF 3-SUBSTITUTED MORPHOLINES  
USING COMPUTER-GUIDED CATALYST DESIGN 
1.  INTRODUCTION 
Enantioselective methods for the synthesis of substituted morpholines are sought after due 
to their paucity. Many pharmaceuticals and natural products contain C-substituted morpholines, 
including the appetite suppressant phendimetrazine, the antidepressant reboxetine, and the plant 
alkaloid polygonapholine, a component of a tonic used in traditional Taiwanese medicine  
(Figure 1).88–92 Additionally, bupropion, an anti-depressant and smoking cessation aid, undergoes 
metabolic oxidation and ring closure to form the active morpholine compound 33 (Scheme 18).93 
Chiral, enantioenriched acylmorpholines have been used as a subunit of peptides and 
peptidomimics, where conformation is controlled by the six-membered morpholine ring.94,95 
 
Figure 1. C-Substituted Morpholines of Interest 
Scheme 18. Conversion of Bupropion to Active Metabolite 33 
 
Chiral, enantioenriched, C-substituted morpholines are also useful tools in synthetic 
chemistry. They may behave as enantioselective organocatalysts for aldol,96,97 Michael,96,98 and 
aziridination99 reactions, and dialkylzinc addition to aldehydes.100 These cyclic compounds are 
also useful as chiral auxiliaries for the diastereoselective synthesis of propargylamines101 and 
tetrahydropyridines.102 The diversity of morpholines that have been used for these purposes is 
limited only to a few, readily-available compounds, synthesized from a few chiral pool α-amino 
acids. Morpholines may also be used as precursors to enantioenriched α-amino acids103 and  
1,2-amino alcohols.104   
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2.  BACKGROUND 
2.1 The Enantioselective Synthesis of Morpholines 
2.1.1 Prior Art 
 The preparation of enantioenriched, C-substituted morpholines has traditionally depended 
on the stepwise annulation of two C2 units with preinstalled, stereogenic centers.105–111 Most 
commonly, a chiral, enantioenriched amino alcohol 34 is coupled with a bis-electrophile such as  
α-chloro acetyl chloride 35, followed by reduction of the resultant morpholinone 36 to yield 
morpholine 37 (Scheme 19). Diastereoselection may also occur in the case of a chiral 
electrophile.112 Overall, this and similar approaches require several steps, are plagued by low 
yields, and often necessitate protecting group strategies.113–116  
Scheme 19. Synthesis of Morpholines from Enantioenriched Amino Alcohols 
 
 An alternative strategy has been to resolve the enantiomers of racemic morpholines by 
chiral stationary phase chromatography, by formation of diastereomeric derivatives and their 
separation, or by kinetic resolution.117–119  
 A more enticing possibility is one-step enantioselective cyclization to the morpholine. 
Schafer has reported a one-pot alkyne hydroamination and enantioselective imine reduction of 
amino propargyl ethers 38, using sequential Ti catalysis and Ru catalysis to form 3-substituted 
morpholines enantioselectively (Scheme 20).120 Although product enantiomeric ratios were 
generally in excess of 98.5:1.5, little functional group compatibility was demonstrated.  
Scheme 20. Schafer’s Hydroamination-Reduction to form Enantioenriched Morpholines 
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2.1.2 SnAP Morpholine Synthesis 
Most recently, Bode and coworkers have developed a morpholine synthesis based on SnAP 
(the stannyl amine protocol). SnAP chemistry offers an air- and moisture-tolerant, one-pot 
synthesis of many nitrogen heterocycles, such as piperazines and morpholines, without the use of 
protecting groups.121–124 A wide range of pendant moieties derived from alkyl and (hetero)aryl 
aldehydes may be incorporated, and the method is compatible with diverse functional groups. 
Pendant (alkyl or aryl) halides, phenols, ethers, aldehydes, esters, tertiary amines, amides, 
carbamates, pinacolboronates, nitriles, and nitro groups have all shown compatibility with the 
reaction conditions. Many SnAP reagents are commercially available,125 and can be made on 
multi-gram scale.  
An initial report by Bode and coworkers detailed the synthesis of 3-substituted morpholines 
37 from SnAP M 38a (R1 = H) with aliphatic or (hetero)aryl aldehydes or glyoxals 39  
(Scheme 21).126 SnAP M may be made in four steps from commercially-available 
tributyl(iodomethyl)stannane and ethylene glycol.  
Scheme 21. Stoichiometric SnAP Morpholine Synthesis 
 
After initial formation of imine 40, it is hypothesized that CuII oxidizes the stannane to a 
carbon-centered radical IV, with concomitant protonation of the imine (Scheme 22).124 The 
resultant α-alkoxy radical attacks the iminium to form a N-centered radical cation V, which is 
reduced by the CuI generated in the first step, to form a morpholine 37. The facile, intramolecular 
cyclization of this radical intermediate may explain the wide functional group compatibility and 
substrate scope of the reaction. Although this is a redox-neutral process, initially, a stoichiometric 
amount of CuII was required, since it appears that the Lewis basic products inhibit the reaction. 
Furthermore, aldehydes such as 2-pyridylcarboxaldehyde with proximal Lewis basic 
functionalities do not undergo cyclization.  
  
29 
 
 
Scheme 22. Putative Mechanism for SnAP Morpholine Synthesis 
 
A breakthrough in SnAP chemistry was made when ligands were identified to allow for 
substoichiometric loadings of CuII (Scheme 23).127 Although a number of ligand classes were 
screened, single-carbon-bridged bisoxazolines significantly outperformed all others, though 
extensive variation was observed within this class. Additionally, a decrease in the CH2Cl2/HFIP 
ratio of the solvent (or use of 100% HFIP) dramatically increased yield in the substoichiometric 
reaction, possibly by stabilizing the Lewis basic products by hydrogen-bonding.  
Scheme 23. SnAP Reagent Synthesis of Morpholines 
 
Under the substoichiometric protocol, morpholines 37 can be formed in excellent yield. 
The scope of aldehydes 39 included pendant phenols, esters, aryl pinacolboronate esters and 
protected heterocycles. Where R1 = Me or Et, the diastereomeric ratio of all published examples 
has been >20:1 anti:syn. In any case involving substituted SnAP reagents, the more 
thermodynamically stable product is formed.  
The substoichiometric protocol also paves the way for a synthetically useful, 
enantioselective process. Indeed, Bode was able to produce one example of a ligand,  
(S,S)-Ph-box, capable of forming enantioenriched morpholines from SnAP M 38a (Scheme 24). 
Morpholine 37a was produced in 80% yield, 80:20 er, and ≥20:1 dr. This result gives credence to 
the hypothesis that SnAP cyclization proceeds via an intermediate, achiral radical such as IV.  
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A stereoconvergent mechanism must be in operation, favoring one enantiomer of product from 
racemic precursor 40a. Although this result is promising, the enantioselectivity so far is moderate. 
Additionally, since Bode’s proposed mechanism (Scheme 22) does not involve the metal in the 
stereodetermining step, the true mechanism must differ from this.   
Scheme 24. Enantioselective Cyclization of Ethyl SnAP M 38b 
 
A new, putative catalytic cycle is proposed (Scheme 25). After formation of the initial, 
achiral radical intermediate VI, the Cu bisoxazoline complex is coordinated to the Lewis basic  
N atom during cyclization to VII, allowing enantioselection. Rather than producing a radical cation 
bound datively to a reducing CuI species, it is likely that this process would form a CuII amide, 
which must be protonolysed to release morpholine 37 to allow catalytic turnover.  
Scheme 25. New Proposed Catalytic Cycle 
 
 SnAP chemistry has also been used to make a wide variety of other N-heterocycles, 
including piperazines, thiomorpholines, spirocycles and fused bicycles, and 7–9-membered 
rings.121–124,128 Ketimines formed from cyclic ketones or trifluoromethyl ketones may be used in 
place of aldimines as substrates.  
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2.2 Computational Background 
Bode’s promising result is a perfect candidate for the Denmark group’s long-running 
interest in chemoinformatic optimization, with the aim to improve the suboptimal 
enantioselectivity. The group’s chemoinformatic screening, developed by Jeremy Henle and 
Andrew Zahrt, involves selection of a maximally-diverse training set of ligands using a Kennard-
Stone algorithm, from a very large in silico library of potential ligands. This strategy provides 
maximal diversity of the training set within chemical space, with some user-defined restrictions 
for ease of synthesis or from experimental determination of viable ligands.  
2.2.1 The in silico Library 
For the in silico library, only single-carbon-bridged bisoxazolines 41 with points of 
diversity at R1, R2, R3 and R4 were chosen (Figure 2). Based on literature results from the field of 
bisoxazoline catalysis and the proximity to the metal, the library had been made to include the 
greatest diversity at R1, with 166 possible substituents, including alkyl, aryl, and benzyl groups, 
and their heteroatom- and functional group-substituted analogs (Figure 3).129 R2 and R3 were 
chosen to be H, Me, t-Bu, Ph, p-MeO(C6H4) or p-F3C(C6H4). For synthetic ease, an additional 
constraint was issued such that when neither R2 ≠ R3, one of the two must be H, and no di-t-butyl 
substitution was permitted at C5. Lastly, R4 must be H, Me, or a 3–6-membered carbocycle. After 
these constraints, the combinatorial library contained 15936 members, created from all permissible 
combinations of R1, R2, R3, and R4.  
 
Figure 2. Bisoxazoline Points of Diversity and Standard Atom Numbering 
At this point, electrostatic and steric interaction parameters are calculated for each of the 
potential ligands, followed by the calculation of descriptors, which allow the compounds to be 
mapped in multidimensional chemical space. A Kennard-Stone algorithm is applied to calculate 
the representative training set of ligands to be synthesized and tested, which reduces the original 
library of 15936 bisoxazolines to 39 representative ligands. Since the effects of each substitution 
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may be computationally deconvoluted, this is akin to testing a library of ∏ 𝑛𝑖
 
𝑖  potential catalysts 
(where i are the possible substituents and n the four points of diversity), without the extreme 
synthetic overhead. The bisoxazoline training set was made to contain 39 ligands (Figure 4). The 
aim of multiple projects in the Denmark group and between our collaborators was to synthesize 
the ligands of the training set, and test their merits in various enantioselective reactions.  
2.2.2 Computational Modeling 
From empirical enantioselectivity results, a quantitative structure-selectivity relationship 
(QSSR) is computationally determined. A QSSR compares structural parameters of a library of 
ligands to their selectivity, for example for binding a series of biological receptors. In this work, 
the QSSR will be between descriptors (calculated from electronic and steric parameters) of the  
in silico library of bisoxazolines, and their selectivity as ligands for the copper-catalysed 
enantioselective SnAP synthesis of C-substituted morpholines. Modeling will be performed using 
n-component partial least squares, and k-fold cross-validation, to test for overfitting.  
Through this model, an optimal catalyst for the reaction will be predicted. Predictive 
catalyst modeling is a powerful field, thus far in its infancy, so this could be an exceptionally 
powerful tool for catalyst optimization.130–135 The current state of the art is overwhelmingly 
retrospective explanation of a QSSR. Furthermore, since all calculations are based on the ligand 
alone, the library is applicable for predictive modeling of any reaction experimentally determined 
to be amenable to bisoxazoline catalysis. The group is taking advantage of this property to apply 
the library and initial training set to the optimization of other enantioselective reactions.  
After an initial round of modeling, a small set of predicted catalysts are predicted for the 
reaction in question. These catalysts will in turn be synthesized and tested. If the data remain 
unsatisfactory, they too will be used to refine the model. An improved model is generated, and its 
predictive qualities tested in the same way. After some number of iterations, the model will be able 
to predict an optimal catalyst for this reaction, so long as the data spread is sufficient, and the 
optimal structure is within the domain of applicability of the model.  
In the following sections, bisoxazolines 41 from the training set will be designated by their  
R1 group for distinction.  
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Figure 4. Final Training Set (Structures 1–20) 
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Figure 4 (cont.). Final Training Set (Structures 21–39) 
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3. BISOXAZOLINE SYNTHETIC PLANS 
3.1 General Retrosynthetic Plans 
Only one training set bisoxazoline was already known in the literature.136 However, 
multiple  procedures exist for bisoxazoline cyclization from 1,2-amino alcohols 34 (Scheme 26).129 
These cyclizations may be made either retentive or invertive with respect to a stereocenter adjacent 
to the hydroxyl group, when present. Cyclization is often slow, many literature bisoxazolines only 
being formed after multiple days at reflux, although removal of the H2O byproduct from the 
reaction mixture may speed up the reaction.  
Scheme 26. Stereodivergent Cyclizations of Amino Alcohols 34 
 
Synthesis of the 39 enantioenriched precursor amino alcohols 34 for the bisoxazoline 
training set is vastly more challenging. Where C5 is unsubstituted, the N-protected amino acid 42 
may be synthesized and then reduced by a number of methods, commonly LiAlH4, borane, or 
NaBH4-iodine (Scheme 27).
137,138 A Boc protecting group gives higher yields during the reduction 
step.  
Scheme 27. Reduction of Amino Acids 42 
 
Where C5 is disubstituted (ie: R2 = R3 ≠ H), the amino alcohol may be made from the 
amino acid 42 by esterification, followed by a double Grignard (or organolithium) addition 
(Scheme 28).139 Again, use of a Boc protecting group tends to afford higher yields in the 
organometallic addition step.  
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Scheme 28. Tertiary Amino Alcohol Formation from Esters 
 
The case where C5 is a stereocenter (R2 ≠ R3, where according to our constraints one 
substituent must be H) is complicated by the potential for the formation of diastereomers. The 
precursor Boc-protected ketone 44 may be made selectively from the Weinreb amide 45 or 
morpholine amide 46, without over-addition to form the tertiary alcohol (Scheme 29).140–142 The 
stereochemical result of subsequent NaBH4 reduction is inconsistent (and often unsubstantiated) 
in the literature, but typically gives high dr – a subsidiary goal of this project is to ascertain the 
true stereochemical nature of Boc-protected amino alcohols 43 formed via this method.143–147  
Scheme 29. Diastereoselective Reduction of Amino Ketones 
 
3.2 Synthesis of Amino Alcohol Precursors 
Only two of the desired amino alcohols could be produced directly from cheap, chiral pool 
amino acids. The magnitude of difficulty of synthesis of the other enantiopure α-amino acids is 
illustrated by desired 2-cyclopentylglycine 47a being the sole subject of a Tetrahedron Lett. 
synthesis paper.148 This work required five steps to form the unprotected amino acid as a single 
enantiomer and in 33% overall yield from reasonably-priced, commercially-available precursors, 
using an enantiopure, chiral amino alcohol template (Scheme 30).149  
Scheme 30. Synthesis of (S)-2-Cyclopentylglycine 47a 
 
However, most of the required amino alcohols were made from their corresponding α-
amino acids. These in turn were synthesized through a variety of precedented procedures  
(Chart 2). Alternatively, amino alcohols could be made from enantioenriched 1,2-diols, made via 
the Sharpless AD reaction, using cyclic sulfates as electrophilic intermediates.150,151 
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Chart 2. Methods used for Amino Acid Synthesis 
Method Example 
Chiral pool amino acids Isopropyl bisoxazoline 
Racemic synthesis and resolution 5-Benzodioxolyl bisoxazoline 
Chiral auxiliary methods Cyclopentyl bisoxazoline 
O’Donnell alkylation 3-Methylbenzyl bisoxazoline 
Enantioselective Strecker reaction 4-Tetrahydropyranyl bisoxazoline 
Corey-Link reaction Initial attempt: 2-methoxyphenyl bisoxazoline 
(vide infra) 
  Where R1 was benzylic, the relevant benzyl bromide could be used to install the group via 
an O’Donnell alkylation of a doubly-protected glycine.152,153 Synthetic routes to these ligands were 
prepared by Andrew Zahrt, and as such will not be discussed here in further detail.  
4. BISOXAZOLINE SYNTHESIS 
2-Naphthyl Bisoxazoline 41b 
 
 The first bisoxazoline to be made was the 2-naphthyl bisoxazoline, following a literature 
procedure.136 Firstly, a Bucherer-Bergs reaction was used to synthesize hydantoin 48b in high 
yield (Scheme 31). Hydrolysis with aqueous KOH at 115 °C in a sealed tube followed. The racemic 
amino acid 47b was esterified in excellent yield, and the amine protected with a trifluoroacetyl 
group, which has been found to increase yields for the addition of Grignard reagents to amino 
esters. After the double addition of methylmagnesium bromide, the protecting group was removed 
quantitatively with KOH in aqueous methanol. Enantiomeric resolution was effected with  
(S)-N-formylphenylalanine, resulting in enantiopure amino alcohol 34b, albeit in only 26% yield 
from the racemate. The bisamide 49b was formed from dimethylmalonyl dichloride, and 
cyclization to 41b was effected by reflux in xylene in the presence of 10 mol % Ti(Oi-Pr)4.  
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It was hoped that this synthesis would be didactic with respect to the synthetic routes 
chosen for other bisoxazolines, particularly the successful choice of protecting group and the ease 
of bisamide formation and Ti-mediated cyclization. However, the Bucherer-Bergs route was 
disadvantageous for generalization since an enantioselective variant is unknown, and this 
enantiomeric resolving agent is likely not applicable to a wide range of amino alcohols.   
Scheme 31. Itagaki’s Synthesis of 2-Naphthyl Bisoxazoline 41b 
 
Isopropyl bisoxazoline 41c 
 
Bisoxazoline 41c is the only ligand of this training set whose R1 group corresponds to the 
α-moiety of a chiral pool amino acid, in this case L-valine. Starting from commercially-available 
Boc-L-valine 42c, Weinreb amide 45c was formed in 97% yield without epimerization, by a 
literature procedure (Scheme 32).154 Although reaction of similar Weinreb amides with Grignard 
reagents has often resulted in excellent yields, small changes in substrate structure have been 
shown to result in large variability in ketone yield, so 2.5 equiv 4-methoxyphenyllithium was 
produced and added to 45c at −78 C to give novel α-amino ketone 44c in 68% yield, after an  
in situ quench with saturated aqueous NH4Cl solution, again without epimerization.
143,155 This 
standard organolithium addition procedure was later confirmed within the group to cause very 
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little to no epimerization, even with substrates such as arylglycine derivatives, with much more 
labile stereocenters. NaBH4 reduction of 44c at −20 °C next proceeded to give 1,2-amino alcohol 
43c with complete diastereoselectivity.  
Scheme 32. Synthesis of Amino Alcohol 43c 
 
Literature NaBH4 reduction procedures for various N-alkoxycarbonyl α-amino ketones, 
while often reporting excellent diastereoselectivity, give mixed opinions on the relative 
configuration of the product that is formed, generally without evidence. To prove the relative 
configuration of the amino alcohol, diastereomeric oxazolidinones 50c were formed separately 
(Scheme 33). Comparison of their spectral data to each other and to literature values confirmed 
that the NaBH4 reduction had been erythro-selective, ie: it had produced amino alcohol  
(1R,2S)-43c (Table 4).156 Cis-oxazolidinones generally show larger 3JH4–H5 coupling constants and 
higher field C4 and C5 13C chemical shifts than their trans-analogs. The erythro-selective 
reduction was later confirmed to be general for other substrates, through oxazolidinone formation 
and NOE studies in our laboratories.   
Scheme 33. Stereodivergent Formation of Oxazolidinones 50c 
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Table 4. NMR Data for Oxazolidinones 50c and 51 
 
 cis-50c trans-50c cis-51 trans-51 
3JH4–H5 / Hz 8.1 5.5 8.1 4.8 
δ H4 3.85 3.53 3.93 3.64 
δ H5 5.62 5.16 5.65 5.23 
δ C4 63.1 66.0 61.4 64.8 
δ C5 81.1 81.4 81.3 81.5 
 
Acid-mediated deprotection attempts of 43c with TFA in CH2Cl2/H2O, HCl/Et2O, 
HCl/dioxane, TMSCl, and TMSI gave partial invertive cyclization from the Boc group to 
oxazolidinone trans-50c, presumably due to the stabilization of a full or partial cationic charge 
adjacent to the electron-donating 4-methoxyphenyl group (Scheme 34). However, oxazolidinone 
trans-50c also provided a route to almost quantitative deprotection of the Boc group via  
NaOH-mediated oxazolidinone cleavage, yielding pure, unprotected amino alcohol 34c after 
recrystallization (Scheme 35). Inversion of stereochemistry at this early point in the synthesis may 
be advantageous, compared to manipulation of the stereocenter in the last (bisoxazoline 
cyclization) step, as is required with a one-step Boc deprotection.  
Scheme 34. Attempted Acidic Deprotection of 43c 
 
Scheme 35. Preparation of Unprotected Isopropyl Amino Alcohol 34c 
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The formation of bisamide 49c proceeded smoothly using diacid chloride 52a  
(Scheme 36). A retentive cyclization using Bu2SnCl2 yielded isopropyl bisoxazoline 41c in 67% 
yield after two recrystallizations, with no visible meso-diastereomer.  
Scheme 36. Final Steps to Isopropyl Bisoxazoline 41c  
 
5-Benzodioxolyl Bisoxazoline 41d 
 
 The initial synthetic plan for 5-benzodioxolyl bisoxazoline 41d involved producing the 
enantiopure amino acid via the modified Corey-Link reaction for arylglycine synthesis.157  
  Although formation of the racemic trichloromethyl alcohol 53d from piperonal was known 
and reproducible, it had been reported that subsequent Jones oxidation to form ketone 54d was 
unsuccessful, presumably due to the lability of the benzodioxolane under strongly acidic 
conditions.158 PDC and freshly-prepared bipy chlorochromate were initially tested in place of the 
Jones reagent, due to their compatibility with the benzodioxolyl group (Table 5, entries 1–2).159 
However, very low conversion was obtained based on NMR spectroscopy on the crude mixture. 
Although the bipy chlorochromate oxidation showed little undesired reactivity in 3 h, when instead 
heated and let run for 24 h, yield remained poor, yet side-products were formed (Table 5, entry 3).  
A number of other oxidants were screened, a selection being shown in Table 5. Strongly-
oxidizing species including RuO4,
160 KMnO4,
161 and nickel peroxide “NiO2”162–165 did not produce 
the desired product (Table 5, entries 4–6). The milder oxidants MnO2 (both a commercial source 
and freshly-made)166,167 and BaMnO4
168 gave rise to poor yields and many side-products (Table 5, 
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entries 7–8). Catalytic TEMPO showed a useful yield (69%) of ketone, although roughly 30% of 
a mixture of side-products was also obtained (Table 5, entry 14).169 However, PCC oxidation was 
highly successful, giving a 93% isolated yield of ketone 54d with 3 equiv oxidant (Table 5, entry 
15). This result was surprising in the light of its substantial superiority over the other, similar CrVI 
oxidants. The product was isolated simply by Kugelrohr distillation away from the residual 
chromium byproducts.  
Following on from this success, a CBS reduction yielded the Corey-Link substrate, 
enantioenriched alcohol (R)-53d in 89% yield and 96.5:3.5 er (Scheme 37).157,170 
Table 5. Screening Conditions for Oxidation of Trichloromethyl Alcohol 53d 
 
Run Oxidant Temperature, 
°C 
Solvent Time, h Conversion, 
%a 
Yield, 
%a 
1 1.1 equiv PDC rt CH2Cl2 15 45 20 
2 3 equiv bipy 
HCrO3Cl 
rt CH2Cl2 3 29 23 
3 3 equiv bipy 
HCrO3Cl 
40 CH2Cl2 24 62 35 
4 25 mol % RuO2,  
2 equiv NaIO4 
rt CCl4/H2O 8 2 0 
5 6 equiv KMnO4 rt PhMe 24 7 0 
6 2 equiv NiO2 50 then 111 PhMe 19 + 12 20 0 
7 8 equiv MnO2 81 Cyclohexane 24 83 50 
8 5 equiv BaMnO4 40 CH2Cl2 48 100 17 
9 20 mol % TEMPO,  
3 equiv PhI(OAc)2 
rt CH2Cl2 21 100 69 
10 3 equiv PCC 40 CH2Cl2 24 100 96 (93)b 
a By NMR analysis. b Isolated yield.  
Scheme 37. CBS reduction of benzodioxolyl ketone 54d 
 
The azidation step was then attempted, using literature conditions for electron-rich aryl 
substrates.157 A low conversion of 23% leading to a mixture of products was obtained after removal 
of the starting material by acid-base extraction (Table 6, entry 1).  
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Table 6. Screening Conditions for Azidation of Benzodioxolyl Alcohol 53d 
 
Run Base Additive DME:H2O 
Ratio 
Temperature,  
°C 
Conversion, 
%a 
1 DBU - 2.75:1 rt 24 
2 DBU 1 mol %  
18-crown-6 
2.75:1 rt 25 
3 DBU 10 mol % 
BTEACl 
2.75:1 rt 26 
4 DBU - 2.75:1 40 22 
5 NaOH - 2.75:1 rt 34 
6 Cs2CO3 - 2.75:1 rt 9 
7 DBN - 2.75:1 rt 25 
8 4 equiv 
NaOH 
- 1:4.3 rt 51 
9 NaOH - 1:4.3 rt 31 
a Mass balance reported of impure material after starting material removed via basic extraction 
Addition of 1 mol % 18-crown-6 or 10 mol % of the PTC BTEACl did not significantly 
alter the conversion (Table 6, entries 2–3), despite literature precedent.171 An increase in 
temperature to 40 °C also effected little change (Table 6, entry 4), other than the reaction mixture 
appearing more homogeneous. In no case was racemization of starting material observed.  
Since 2-methoxyphenyl amino acid 42e has been reported to be made via the aryl Corey-
Link procedure and is relevant toward the synthesis of training set bisoxazoline 41e, enantiopure 
trichloromethyl 2-methoxyphenyl carbinol (R)-53e was also synthesized in an attempt to reproduce 
the literature conditions (Scheme 38).157 The PCC oxidation conditions used for benzodioxolyl 
trichloromethyl alcohol 53d were again successful on this substrate, forming trichloromethyl 
ketone 54e in 86% yield (compared to 60% yield for the literature Jones oxidation). CBS reduction 
was again highly effective.  
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Scheme 38. Enantioselective Synthesis of 2-Methoxyphenyl Alcohol 53e toward Bisoxazoline 41e 
 
However, the azidation step, described as proceeding in 40% yield over two steps after 
azide reduction with only minimal racemization to 98.5:1.5 er, was not reproducible in these 
laboratories. Using freshly-distilled DBU as base, only a 13% mass yield of a complex mixture of 
substances was obtained once starting material was removed via basic extraction.  
Base and Solvent Screen for Corey-Link Reactions 
A small base and solvent screen was executed on racemic alcohol 53e, in work performed 
with Jeremy Henle. Although weak organic bases gave no reactivity (Table 7, entry 2), the amidine 
base DBN offered a similar yield to the slightly less basic DBU, as did TBAOH (Table 7,  
entries 3–4). Since Aitken’s work used unpurified DBU, one run was performed using DBU that 
appeared pure by NMR, from the bottle without further purification – this gave no conversion, and 
the starting material was recovered cleanly with no racemization (Table 7, entry 5). All other runs 
used DBN or DBU distilled recently from BaO, or pyridine or DIPEA distilled freshly from CaH2. 
A change in solvent to allow full solubility of the substrate did not promote conversion (Table 7, 
entries 6–7).  
Despite these attempts, the azide was not able to be isolated as a pure compound in the 
yield described in the original work. Although starting material could be recovered cleanly, the 
product mixture always contained multiple compounds. Submitting this crude reaction mixture to 
hydrogenative azide reduction with Pd/C, as in the literature, was unproductive.  
Due to the irreproducibility of the literature protocol, a new synthetic route was chosen for 
the synthesis of 5-benzodioxolyl bisoxazoline 41d, which was successfully performed between 
Jeremy Henle, Kevin Robb, Dr Yang Wang, and Robert Zhang in the Denmark group (synthetic 
route designed by Dr Yang Wang and the author of this document).  
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Table 7. Screening Conditions for Corey-Link Azidation 
 
Run Base Solvent Conversion, 
%a 
1 DBU 1:1.2 DME/H2O 13 
2 pyridine 
or DIPEA 
1:1.2 DME/H2O 2 
3 DBN 1:1.2 DME/H2O 10 
4 TBAOH 1:1.2 DME/H2O 12 
5 DBUb,c 1:1.2 DME/H2O 0 
6 DBUd 1:1 THF/H2O 0 
7 DBUd MeOH 0 
a Mass balance reported of impure material after starting material removed via basic extraction. b Substrate had 99:1 
er and was recovered without racemization. c DBU was used from the bottle without further purification. d Work done 
by Jeremy Henle. 1 mol % 18-crown-6 was added.  
Both a Strecker reaction and a Bucherer-Bergs reaction only gave very low yields of amino 
acid 47d; however the low cost of the starting materials allowed enough to be produced to effect 
a DKR to form Ni complex 56 (Scheme 39). Hydrolysis of 56 produced (S)-47d in 99:1 er. The 
amine was then protected with a Boc group to form 42d quantitatively without racemization.  
Scheme 39. Enantioselective Synthesis of Boc-protected Amino Acid 42d 
 
From this point, the route converged with the earlier proposed synthesis. As with isopropyl 
bisoxazoline 41c, CDI proved an effective reagent for the formation of Weinreb amide 45d, with 
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only minimal epimerization to 96:4 er (Scheme 40). The aforementioned organolithium addition 
conditions were modified slightly for solubility, yielding ketone 44d in 89% yield and 94:6 er. 
NaBH4 reduction again proceeded as for the isopropyl bisoxazoline precursor, giving  
erythro-N-Boc amino alcohol 43d in 93% yield as a single diastereomer. The electron-deficient  
4-trifluorophenyl group this time allowed TMSCl deprotection to proceed smoothly, unlike the 
previous synthesis involving a 4-methoxyphenyl group.  
Scheme 40. Synthesis of Amino Alcohol 34d 
 
Following this, bisamide formation proceeded using similar conditions as for the isopropyl 
bisamide, benzodioxolyl bisamide 49d being formed in roughly 9:1 dr, as would be statistically 
expected from the coupling of two amino alcohols of 94:6 er (Scheme 41). The mixture of 
diastereomers was invertively cyclized via the bismesylate to bisoxazoline 41d, which could be 
separated from the meso-diastereomer via column chromatography. A statistical mixture of 
products would lead bisoxazoline 41d to be formed with 99.6:0.4 er.  
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Scheme 41. Final Steps to Benzodioxolyl Bisoxazoline 41d 
 
4-Tetrahydropyranyl Bisoxazoline 41f 
 
 Tetrahydropyranyl bisoxazoline 41f is the only member of the training set with a saturated 
heterocycle at R1. The synthesis of the enantioenriched amino acid 47f was performed by Jeremy 
Henle according to the method of Jacobsen.172 Despite successes of this method with other amino 
acid syntheses in the group, 47f was formed with only low er (not exactly quantified due to lack 
of chromatographic separation). The amine was then protected with a Boc group, and amidated to 
Weinreb amide 45f (Scheme 42). This reaction was slow, giving 77% yield after 38 h. Attempts 
to use other coupling reagents only further decreased the yield or the rate of the reaction. Addition 
of 3 equiv PhLi gave amino ketone 44f, the er being measured as only 79:21. Reduction with 
NaBH4 proceeded in high yield to give a single diastereomer of 43f.  
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Scheme 42. Synthesis of Tetrahydropyranyl Amino Alcohol 43f 
 
 In analogy to isopropyl bisoxazoline 41c, the oxazolidinone 50f was next formed with the 
intention of effecting a two-step deprotection of the Boc group (Scheme 43). LiOH deprotection 
was attempted, but even under refluxing conditions, no conversion was observed. Since the 
substrate was insoluble in the reaction mixture, hydrolysis was next attempted with K2CO3 in 
MeOH. Although the substrate now dissolved, again no conversion was observed after 12 h at 
reflux – a similar result was obtained with Ba(OH)2 in H2O/1,4-dioxane. The stronger nucleophile 
LiOOH was generated in situ from LiOH and H2O2, but again in refluxing H2O/THF, no 
conversion was observed. A last attempt was made using 6 N HCl. After 24 h at reflux, a complex 
mixture of substances oiled out of the reaction, and no starting material was recovered.  
Scheme 43. Synthesis of Oxazolidinone trans-50f 
 
 Contrary to the synthesis of bisoxazoline 41f, the oxazolidinone was not readily cleaved. 
Since there is no electron-donating group at C5, a TMSCl deprotection was performed, which 
caused quantitative deprotection of the Boc group. Amino alcohol 34f was then reacted with 52a 
to form bisamide 49f.   
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Scheme 44. Synthesis of Bisamide 49f 
 
 Invertive cyclization to the bisoxazoline 41f was then attempted using MsCl and Et3N.  
However, no conversion occurred under these conditions. When next, 10 mol % DMAP was 
added, a complex mixture of products was observed. Harsher conditions involving  
1:1 MsCl/pyridine as the solvent also failed to yield any bismesylate or bisoxazoline.  Further 
attempts to cyclize bisamide 49f were put on hiatus since at this point in time the group had 
sufficient ligands for testing. This synthesis will be revisited in future. This synthesis also 
serves as an example that small changes in bisoxazoline structure (as for isopropyl 
bisoxazoline 41c, this ligand has R1 = secondary alkyl and R3 = aryl) may necessitate 
restructuring of the synthetic plan.  
5. ENANTIOSELECTIVE SNAP SYNTHESIS OF MORPHOLINES 
 Bode’s single example of an enantioselective catalyst for the SnAP morpholine 
synthesis seemed an opportune potential medium to test these bisoxazoline ligands as part of 
the larger set generated in conjunction with other members of the Denmark group.  
 To recapitulate, Bode and coworkers developed a general, one-pot morpholine 
cyclization compatible with a wide range of pendant functionality. Although only one 
enantioselective catalyst is published, this transformation is the first of its kind.127 Despite 
screening a number of substrates (Table 8) and bisoxazoline-type ligands (Chart 3), high 
enantioselectivity could not be obtained.173 A number of ligands were therefore tested on this 
reaction by the author, with the aim of generating data sufficient to create a reliable, 
computational model.  
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Table 8. Results of Bode’s Enantioselective Morpholine Synthesis 
 
Entry R Aryl Yield er dr 
1 Et 2-Toluyl 82% 80:20 ≥20:1 
2 Et 4-Triazolylphenyl 80% 72:28 ≥20:1 
3 Et 4-Quinolinyl 73% 70:30 ≥20:1 
4 H 2-Toluyl 70% 82:18 NA 
5 H 4-Anisoyl 77% 77:23 NA 
6 H Phenyl 84% 71:29 NA 
7 H 4-F3C-phenyl a 70:30 NA 
8b H 4-F3C-phenyl a 72:28 NA 
NA = not applicable. Triazolyl = 1-(1H-1,2,4-triazolyl). a 100% conversion; yield not reported. b Cyclization was 
performed at 0 °C.  
Chart 3. Ligand Screen for Bode’s Enantioselective Morpholine Synthesis. conv = conversion 
 
 The imine substrate for screening purposes was generated from p-anisaldehyde 39b, 
since it is readily-available, easily purified by distillation, and gave rise to some of the highest 
yields and enantioselectivities in Bode’s reaction.  
SnAP M 38a was always generated immediately prior to reaction (Scheme 45). 
Although the free SnAP reagent is stable at rt or in a refrigerator for several weeks, 
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phthalimide-protected SnAP M 57 is stable indefinitely, so this practice removes an additional 
variable. The reaction takes only 20 minutes, and the product is purified simply by filtration 
and removal of solvent and residual hydrazine in vacuo. Imine 40 is then formed immediately 
on mixing SnAP M 38a and the relevant aldehyde with powdered MS in CH2Cl2, and purified 
simply by filtration and removal of solvent in vacuo.  
Scheme 45. Generation of Imine 40c Immediately Prior to Cyclization 
 
 Formation of the active catalyst involves mixing equimolar amounts of bisoxazoline and 
Cu(OTf)2 in 1:1 CH2Cl2/HFIP for 6 h at rt. A bold color change immediately occurs, tending to 
intensify over the course of the complexation (Figure 5). The imine is then injected as a solution 
in CH2Cl2, often inducing a second color change, and the reaction mixture stirred at rt for 20 h 
(Scheme 46).  
Scheme 46. Screening conditions for Imine Cyclization to Morpholine 37c 
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Complex formation immediately on Cu(OTf)2 addition 
 
Complex formation after 6 h 
 
Reaction mixtures immediately on imine addition 
 
Reaction mixtures after 20 h 
Figure 5. Appearance of SnAP Reaction Mixtures 
 The results of these reactions are shown in Table 9. Although Bode’s group showed 
low levels of conversion with these ligands on the imine generated from  
4-trifluoromethylbenzaldehyde (maximum: 40%), bisoxazolines with R4 = H (a CH2 bridge) 
showed no conversion with the p-anisaldehyde SnAP imine 40c (entries 20–21, 23, and 25).  
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Table 9. Results of Enantioselective Morpholine Synthesis
Ligand Entry er 
 
 
1a 32:68 
1b 31:69 
 
 2a 29:71 
2b 30:70 
 
 
3a 35:65 
3b 35:65 
 
 
4a 24:76 
4b 25:75 
 
 
5a 23:77 
5b 22:78 
 
 
6a 37:63 
6b 36:64 
 
7a 27:73 
7ba 32:68 
7c 26:74 
 
 
8a 37:63 
8b 36:64 
 
 
9aa 59:41 
9b 67:33 
9c 68:32 
 
 
Ligand Entry er 
 
 10aa 13:87 
10b 17:83 
10c 18:82 
 
11a 36:64 
11b 35:65 
 
 
 
12a 28:72 
12b 27:73 
 
0.028 mmol scale 
 
13a 49:51 
13b 50:50 
 
 
14a 43:57 
14b 44:56 
 
 
 
0.036 mmol scale 
15a 37:63 
15b 36:64 
 
 
 
16a 47:53 
16b 48:52 
 
 
 
17a 63:37 
17b 63:37 
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Table 9 (cont.). Results of Enantioselective Morpholine Synthesis
 
18a 47:53 
18b 47:53 
 
19a 36:64 
19b 36:64 
 20 NR 
 
21 
 
NR 
 
 
22 
 
 
 
NR 
 
 
 
 
23 
 
 
NR 
 
 
 
24 
 
 
NR 
 
 
 
25 
 
 
 
NR 
 
 
 
 
26 
 
 
NR 
 
 
NR = 0% yield of morpholine. a Anomalous result.  All results not within ±2% ee were repeated until consistency was 
reached. The anomalous data were excluded from analysis 
The data show a broad spread, indicating they may be suitable for computational model 
generation (Chart 4). Ligands which induced no reactivity will not be included in analysis toward 
the model. Values between 50:50 and 82:18 er are represented, with mean 65.3:34.7 and median 
64:36 er. Chart 4 shows that although many data are clustered around the 63:37 er (26% ee) region, 
the rest of the data are more evenly spread.  
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Chart 4. Box Plot showing Quartile Distribution of Morpholine er. × = mean value 
 
In general, it appears that aryl groups at R1 give rise to higher selectivities than benzylic 
groups – all the selectivities above 70:30 other than in one case (entry 7) are generated from  
R1 = aryl ligands. Average er from aryl bisoxazolines (69.4:30.6) is much higher than average er 
obtained from benzyl bisoxazolines (59.1:40.9). Alkyl bisoxazolines also show high average 
enantioselectivity (68.5:31.5), although this is only averaged over three results.  
No obvious result of addition sterics at R1 can be seen for alkyl bisoxazolines, since the 
two t-Bu bisoxazolines gave very different results (entries 6–7), and the isopropyl bisoxazoline 
resulted in enantioselectivity in the middle of these (entry 1).  
Three of the four highest enantioselectivities were produced from bisoxazolines with  
R1 = Ph (entries 4, 5, and 10). The best performing of these had diphenyl substitution. However, it 
is difficult to translate this into a trend, since, the best performing ligand (entry 10) and one of the 
worst (entry 16) both have diaryl substitution at C5. A single methyl or dimethyl substitution at 
C5 gave a low range of selectivity, between 29:71 and 37:63 er (entries 2, 8, and 19). No clear 
relationship between selectivity and simultaneous classes of group at C4 and C5 (eg: aryl-alkyl, 
alkyl-aryl, benzyl-aryl, etc.) is established, and it is notable that a broad range of selectivity is 
observed between the many trans-diaryl ligands.  
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Electron-withdrawing substituents at C5 appear to have a deleterious effect on 
enantioselectivity (entries 4 and 12 compared to entries 11 and 13). This may be true even with an 
electron-donating aryl group at R1 (entry 15). However, another case with electron-donating aryl 
groups at both C4 and C5 showed somewhat diminished enantioselectivity (entry 9 compared to 
entry 12). Every case of an electron-withdrawing aryl group at C5 gave rise to below average 
selectivity. However, there appeared to be no advantage of electron-rich over electron-neutral 
substituents at this position.  
Ligands with R4 = Me (2,2’-propanediyl bridge) performed with a wide range of selectivity 
(entries 2, 4, 10, and 14). Direct comparison shows that R4 = Et is favorable to R4 = i-Bu for ligands 
similar to entries 6–7. Small bridging cycloalkanediyl rings seem to be more effective than normal 
rings, and five-membered rings seem to be particularly non-selective (entries 1, 13, and 18).  
As well as the methylene-bridged ligands, the bisoxazoline with R1 = 1-pyrenyl gave no 
reactivity (entry 23). This could be due to the large steric bulk at this position dissuading binding 
of the imine substrate. The lack of reactivity from the p-nitrobenzyl bisoxazoline (entry 25) may 
result from incompatibility of the nitro group with the reaction conditions, although aryl nitro 
groups pendant to the substrate have shown compatibility with the stoichiometric SnAP protocol.  
6. FUTURE WORK 
 A computational model may now be generated, which will recommend a few bisoxazolines 
to be synthesized next, for testing in the morpholine synthesis. The data from these runs will be 
fed back into the model for improvement, and with this broad data spread it may be possible to 
generate a predictive model for catalytic, enantioselective SnAP synthesis of morpholines. This 
can then be extended to more substrates to check the generality of the model.  
 Not only can the model generate new candidate ligands to synthesize, but the areas of 
chemical space lacking representation may be evaluated, to further improve the model. For 
example, no bisoxazolines were tested with an ortho-substituted aryl group at R1 (other than fluoro 
substitution). Any model generated from this data set will be unable to predict the effects of 
substitution here.  
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 After a sufficient model has been generated, it will be important to evaluate the substrate 
scope. The optimal ligand will be tested for its generality for cyclization of SnAP imines from 
other aldehydes, including alkyl aldehydes and glyoxals previously tested by Bode. Other SnAP 
reagents may be tested, with particular interest in evaluating selectivity in reactions where 
diastereomers may be formed.  
 More ligands will need to be synthesized to evaluate the thesis of the computational work. 
Ideally, an entire training set will be synthesized. Since the more troublesome stages of 
bisoxazoline synthesis have been elucidated over the course of this project, a new training set will 
be generated that maintains excellent diversity while allowing for faster synthesis of some of the 
ligands.  Ideally, the state of the art of bisoxazoline synthesis itself will be improved. A late-stage 
functionalization method for bisoxazolines is currently under development in the Denmark 
laboratory.  
 A study on the SnAP synthesis of piperazines using the same ligand set is currently 
underway in the Bode laboratory.  
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EXPERIMENTAL 
General Experimental 
 Reaction Setup: Reactions were performed in oven-dried glassware. Room temperature 
(rt) was approximately 23 °C. Solvent evaporation was performed on a rotary evaporator at 30 °C 
unless otherwise specified.  
Distillation: Bulb-to-bulb distillation was performed using a Kugelrohr, with boiling 
points (bp) corresponding to uncorrected air bath temperatures (ABT) under vacuum. 
Chemicals: Copper(II) bromide, copper(II) triflate, lithium chloride, allylpalladium(II) 
chloride dimer, bis(benzonitrile)palladium(II) chloride, dipalladium(0) tris(benzylideneacetone), 
palladium(II) acetate, tetrakis(acetonitrile)palladium(II) tetrafluoroborate, 
tetrakis(triphenylphosphino)palladium(0), di(1-adamantyl) n-butyl phosphine, rac-BINAP, dppb, 
XPhos, Xantphos, sodium hydride, and dibutyltin dichloride were stored in a glovebox under Ar. 
Note: results of SnAP reactions depend strongly on Cu source. The cause for this is under 
investigation in the Bode group.  
Cesium carbonate, lithium bromide, and sodium borohydride were stored in a dessicator 
over Drierite.  
The following anhydrous reagents and solvents were freshly distilled from the dessicant in 
parentheses: DBN and DBU (BaO), p-cymene, Et3N, i-Pr2NH, TBME, and TMSCl (CaH2), HFIP 
(CaSO4), MeOH (Mg), bromobenzene and anisoyl bromide (molecular sieves), MeCN,  
1,4-dioxane, and DME (Na), and cyclohexane (P2O5). Anhydrous CH2Cl2, DMF, Et2O, hexane, 
THF, and toluene were dried by percolation through two columns packed with neutral alumina 
under positive Ar pressure. Solvent deoxygenation was performed where stated by passing Ar 
through the solvent for 20 min.  
(R)-BINAP and (R)-Tol-BINAP were purified by basic aqueous extraction from toluene, 
trituration with degassed MeOH and subsequent recrystallization from 1:1 toluene:EtOH.174  
CDI was recrystallized from anhydrous benzene. AsPh3 was recrystallized from EtOAc. dppf was 
dissolved in hot dioxane, cooled to rt, and triturated with pentane.  
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Commercially available organolithium and Grignard reagent solutions were titrated 
according to the methods of Gilman and Cartledge,175 and Watson and Eastham176 respectively 
within one month of use.  
NMR Spectroscopy: Spectra were recorded on Varian 500 MHz spectrometers. 1H and 
13C spectra were referenced to residual non-deuterated chloroform (7.26 ppm, 1H; 77.02 ppm, 13C), 
acetonitrile (1.94 ppm, 1H; 1.32 and 118.26 ppm, 13C), benzene (7.16 ppm, 1H; 128.06 ppm, 13C), 
or d6- DMSO (2.49 ppm, 
1H; 39.52 ppm, 13C). 11B chemical shifts are reported relative to an 
external standard of boron trifluoride diethyl etherate (0.00 ppm). 19F chemical shifts are reported 
relative to an external standard of trichlorofluoromethane (0.00 ppm). 31P spectra were referenced 
to an external standard of 85% H3PO4 in H2O (0 ppm). 
13C spectra were recorded with broadband 
decoupling of the 1H nucleus, and 31P spectra with broadband decoupling of the 13C nucleus. 
Chemical shifts are reported in parts per million (ppm), multiplicities indicated by s (singlet),  
d (doublet), t (triplet), sext (sextet), sept (septet), oct (octet), br (broad), and m (multiplet). 
Coupling constants, J, are reported in Hz with integration provided and assignments indicated.  
Infrared Spectroscopy: Infrared spectra (IR) were recorded using a Perkin-Elmer FTIR 
instrument. Peaks are reported in cm-1 with indicated relative absorption intensities: s (strong,  
67–100%); m (medium, 34–66%); w (weak, 0–33%) and sh (sharp) and br (broad) assignments. 
Mass Spectrometry: Matrix-assisted laser desorption/ionization (MALDI) spectrometry was 
performed on an AB Voyager instrument. Electron Impact (EI) spectrometry was performed at  
70 eV using methane as the carrier gas, with a time-of-flight (TOF) mass analyzer. Data are 
reported in the form of m/z (intensity relative to the base peak = 100). Electrospray Ionization 
(ESI) spectra were performed on a Micromass Q-Tof Ultima spectrometer.  
Liquid Chromatography: Analytical thin-layer chromatography (TLC) was performed 
on silica gel 60 F254 plates. Retention factor (Rf) values reported were measured using 10 × 2 cm 
silica TLC plates in a developing chamber containing the solvent system described. Visualization 
was accomplished with UV light and cerium(IV) ammonium molybdate solution (CAM), acidic 
2,4-dinitrophenylhydrazine solution (DNP), potassium permanganate (KMnO4), or a solution of 
silver nitrate and 2-phenoxyethanol with one drop of 30% aqueous hydrogen peroxide and  
UV irradiation for several minutes (AgNO3-H2O2). Flash column chromatography was performed 
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using 40–63 µm particle size (230–400 mesh, 60 Å pore size) SiO2. Analytical high-performance 
liquid chromatography (HPLC) was performed on an Agilent 1100 system using a UV detector 
(254 nm) and a Chiralpak AD-H, IB-3 or OJ-H column. Analytical supercritical fluid 
chromatography (SFC) was performed on an Agilent 1100 HPLC equipped with an Aurora 
Systems A-5 supercritical CO2 adapter for SFC, using a UV detector (220 nm) and a Daicel 
Chiralcel OD column. 
Gas Chromatography: Analytical gas chromatography (GC) was performed using a 
flame ionization detector. Retention times and integrated ratios were obtained from reporting 
integrators. Response factors for quantitative GC analysis were obtained with tetradecane as 
internal standard, using the following equation: response factor of compound = (area of  
compound × amount of standard) / (amount of compound × area of standard). Three samples of 
relative concentration 0.5, 1.0 and 2.0 with respect to internal standard were prepared and dissolved 
in EtOAc. An aliquot of each sample was injected into the GC in quadruplicate. The average of 
the twelve response factors was used for reaction analysis. Injections were made onto a  
Hewlett-Packard HP-1 25 m × 0.2 m × 33 μm capillary column. Injector temperature was 250 °C, 
detector temperature was 300 °C with a H2 carrier gas flow of 16.7 mL min
−1. The column oven 
was programmed to hold the temperature at 140 °C for 2 min, then increase temperature at a rate 
of 50 °C min−1 over 2.4 min and hold at 260 °C for 5.6 min, a total run time of 10.0 min.  
Literature Procedures 
Allyl aryl ethers 17a–17d were prepared according to a literature procedure,24,177 were 
purified via Kugelrohr distillation or sublimation, and had spectroscopic data consistent with the 
literature.  
[Ir(cod)Cl]2
178 was made via a literature procedure, and stored in a desiccator.  
1-Phenylhexane-1,3,5-trione,179 2-Bromobiphenyl,180 and (2-biphenyl)dimethylsilane181 were also 
made according to literature procedures. These compounds had spectral data conforming to the 
literature.  
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EXPERIMENTAL PROCEDURES: CHAPTER 1 
Preparation and Isolation of Palladium Catalyst [(R)-Tol-BINAP 18] 
 
Complex (R)-Tol-BINAP 18 was generated in situ for chlorohydroxylation reactions, and 
a sample was isolated for characterization purposes.  
Bis(acetonitrile)dichloropalladium(II) (20 mg, 77 µmol) was charged to a 10-mL, two-
necked, round-bottomed flask, in a glovebox. Anhydrous, degassed THF (0.5 mL) was added, 
followed by (R)-Tol-BINAP (51 mg, 77 µmol, 1.0 equiv), washing with further anhydrous, 
degassed THF (0.5 mL). The clear, orange-yellow solution was stirred at rt for 30 min. Anhydrous, 
degassed Et2O (3 mL) was added, and a yellow precipitate was immediately produced. The 
solution was filtered, and the filtrand dried in vacuo to 62 mg (77 µmol, 97% yield) of a bright 
yellow powder. Further drying under high vacuum (50 Pa) for over 24 h did not remove residual 
Et2O.  
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Data for (R)-Tol-BINAP 18:  
1H NMR: (500 MHz, d6-DMSO) 
δ 7.73 (d, J = 8.9 Hz, 2 H), 7.70 (d, J = 8.2 Hz, 2 H), 7.61 (dd, J = 11.7, 8.2 Hz,  
4 H), 7.50 (t, J = 7.5 Hz, 2 H), 7.39 (br s, 4 H), 7.33 (d, J = 7.4 Hz, 4 H), 7.14–7.24 
(m, 4 H), 6.63 (d, J = 8.7 Hz, 2 H), 6.53 (br s, 4 H), 2.38 (s, 6 H, H3,AC(15)),  
1.98 (s, 6 H, H3,BC(15)) 
31P NMR: (202 MHz, d6-DMSO) 
28.62 
IR: (KBr; pressed under Ar) 
3416 (s, v br), 3055 (s), 2976 (s), 2920 (s), 2866 (s), 1597 (s), 1557 (m), 1498 (s), 
1444 (m), 1397 (m), 1308 (m), 1224 (w), 1192 (m), 1159 (w), 1101 (s), 1020 (w), 
870 (w), 846 (w), 803 (s), 746 (s), 707 (m), 697 (m), 670 (m), 652 (m), 636 (m), 
621 (m), 614 (m), 602 (m), 530 (m), 523 (m), 508 (s), 475 (m), 454 (m) 
MS: (MALDI; solvent: THF) 
819.96 ([M−Cl]+) 
 
Henry’s Preparation of -(R)-BINAP -1-Phenylhexane-1,3,5-triketone 
Bis[(acetonitrile)palladium(II)] Tetrafluoroborate [(R)-BINAP 18] 
 
The procedure was followed as closely as possible to that in Henry’s report.24  
To a stirred solution of tetrakis(acetonitrile)palladium(II) tetrafluoroborate (100 mg,  
226 µmol, 2 equiv) in anhydrous acetonitrile (4.3 mL) under Ar in a 25-mL, round-bottomed flask 
was added, dropwise, a solution of 1-phenylhexane-1,3,5-trione (23 mg, 113 µmol) in anhydrous 
acetonitrile (2.0 mL). Anhydrous triethylamine (210 µL, 152 mg, 13.4 equiv) was then added 
dropwise, causing a color change from yellow to bold orange. The solution was stirred at rt for  
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30 min. A solution of (R)-BINAP (70 mg, 113 µmol, 1 equiv) in anhydrous benzene (1.3 mL) was 
then added dropwise to the reaction mixture, which was next stirred at rt for 12 h. The mixture was 
concentrated under high vacuum (50 Pa) to a pasty, brick red residue. Anhydrous Et2O (10 mL) 
was added, and the suspension stirred at high frequency for 15 min. Solvent was removed under 
high vacuum to yield a brick red powder. This was washed in a glovebox with anhydrous Et2O  
(5 × 30 mL) to give a yellow-brown powder, which was dried briefly in vacuo to 131 mg yellow-
brown powder (100 µmol, 90% yield). Residual Et2O was not removed by further drying a sample 
in vacuo for over 24 h, and the 31P NMR spectrum did not change after this process.  
Data for (R)-BINAP 15 (Henry’s preparation):  
1H NMR: (500 MHz, d6-DMSO) 
δ 6.95-8.19 (m, 12.09 H), 6.83 (m, 0.41 H), 6.60 (m, 0.01 H), 6.40 (m, 0.12 H), 
6.20 (m, 0.01 H), 5.87 (br s, 0.13 H), 5.43 (br s, 0.04 H), 3.33 (br m, 1.00 H),  
3.07 (br q, J = 6.9 Hz, 11.86 H), 2.92 (br s, 0.14 H), 2.49 (s, 2.99 H), 2.23 (br m, 
0.12 H), 2.06 (s, 0.47 H), 1.74 (s, 0.22 H), 1.67 (s, 0.03 H), 1.16 (t, J = 6.9 Hz, 
20.70 H) 
31P NMR: (202 MHz, d6-DMSO) 
33.28, 33.09, 32.72, 32.51, 32.30 (major peak), 31.76, 31.54, 31.26, 31.06, 28.29, 
25.36, 25.05, 22.32 
IR: (KBr; pressed under Ar) 
3169 (m), 3055 (m), 2986 (m), 2943 (m), 2680 (m), 2492 (m), 1673 (m), 1586 (m), 
1531 (s), 1507 (s), 1478 (s), 1437 (s), 1399 (m), 1384 (m), 1311 (m),  
1056 (s, v br), 872 (w), 847 (w), 815 (m), 746 (m), 697 (s), 668 (m), 619 (w),  
609 (w), 582 (w), 552 (w), 523 (m), 501 (m), 475 (w) 
 
New Preparation of Dinuclear Palladium Catalyst L·18 
To a two-necked, 15-mL, pear-shaped flask charged with a suspension of sodium hydride 
(5.4 mg, 226 mol, 2 equiv) in anhydrous acetonitrile (1.0 mL) at 0 C was added 1-phenylhexane-
1,3,5-trione (23 mg, 113 mol) portionwise under Ar, and the mixture stirred at rt for 15 min. The 
solution turned clear, bright yellow, and H2 evolution was observed. 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (100 mg, 226 mol, 2 equiv) was dissolved 
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in anhydrous acetonitrile (1.5 mL) under Ar in a separate 10-mL Schlenk flask, and cooled to  
−20 C. The solution of deprotonated triketone was added slowly to the palladium-containing 
solution via cannula at −20 C, washing with anhydrous acetonitrile (0.5 mL). The mixture was 
brought to rt, and stirred for 30 min. This was accompanied by a color change to orange. The 
mixture was cooled to −20 C, then a solution of bisphosphine ligand (113 mol, 1 equiv) in 
anhydrous benzene (0.9 mL, 0.2 M in ligand) was added dropwise over 3 min. The reaction mixture 
was stirred at rt for 12 h. It was then concentrated under high vacuum (120 Pa) to a brown powder. 
This was washed in a glovebox with anhydrous Et2O (10 mL), then anhydrous toluene (3 ×  
10 mL), removing a yellow filtrate. The solids were dissolved in anhydrous acetone to yield a 
yellow-brown solution, which was quickly filtered to remove a white solid. The filtrate was 
concentrated under high vacuum (120 Pa), and washed with anhydrous Et2O (4 × 10 mL), then 
anhydrous toluene (3 × 10 mL). The solid was collected. The dinuclear palladium catalysts 
decompose quickly, and decomposition appears to be accelerated under vacuum. The complexes 
must be kept under inert atmosphere, and should be used and characterized without delay.  
New Preparation of -(R)-BINAP -1-Phenylhexane-1,3,5-triketone 
Bis[(acetonitrile)palladium(II)] Tetrafluoroborate [(R)-BINAP 18] 
 
Dinuclear complex (R)-BINAP 18 was synthesized from 
tetrakis(acetonitrile)palladium(II) tetrafluoroborate (226 mol), producing 131 mg (101 mol, 
90% yield) of a yellow-brown powder.  
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Data for (R)-BINAP 18 (new preparation):  
1H NMR: (500 MHz, d6-DMSO) 
δ 8.04 (br d), 7.65–8.00 (br m), 7.60 (br s), 7.52 (br t), 7.38 (br m),  
7.13–7.28 (br m), 7.04 (br), 6.72–6.95 (br m), 6.54 (br d, J = 6.2 Hz), 6.35 (br), 
2.28 (s), 2.06 (s), 1.82 (s), 1.74 (s), 1.67 (s), 1.07 (t, H3C(16)) 
31P NMR: (202 MHz, d6-DMSO) 
33.10 
IR: (powder, under air) 
3694 (w), 3434 (br w), 2924.16 (w), 1439 (w), 1376 (w), 1084 (w), 1023 (w),  
1003 (w), 833 (w), 697 (w), 558 (w), 539 (w), 498 (w), 470 (w) 
 
New Preparation of -(R)-Tol-BINAP -1-Phenylhexane-1,3,5-triketone 
Bis[(acetonitrile)palladium(II)] Tetrafluoroborate [(R)-Tol-BINAP 18] 
 
Dinuclear complex (R)-Tol-BINAP 18 was synthesized from 
tetrakis(acetonitrile)palladium(II) tetrafluoroborate (108 mol) to yield 64 mg (47 mol, 88% 
yield) of a light brown powder.  
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Data for (R)-Tol-BINAP 18:  
1H NMR: (500 MHz, d6-DMSO) 
δ 8.04 (d, J = 7.5 Hz), 7.89 (d, J = 8.6 Hz), 7.73–7.87 (m), 7.35–7.70 (m),  
7.12–7.32 (m), 7.09 (t, J = 7.9 Hz), 6.79 (d, J = 8.5 Hz), 6.49–6.75 (m), 6.40 (s), 
6.31 (s), 5.73 (s), 2.07 (s), 2.06 (s), 1.74 (s, H3,AC(27)), 1.64 (s, H3,BC(27)) 
31P NMR: (202 MHz, d6-DMSO) 
32.39 
IR: (powder, under air) 
3427 (br w), 3058 (w), 1590 (w), 1557 (w), 1437 (w), 1313 (w), 1238 (w),  
1055 (w), 1022 (w), 997 (w), 745 (w), 696 (w), 523 (w), 498 (w) 
 
Preparation of Racemic Chlorohydrin Standards  
Preparation of rac-16b and rac-16c 
Racemic standards of chlorohydrins 16b and 16c were prepared according to a literature 
procedure and had spectroscopic data consistent with the literature.182  
Preparation of rac-(2-Chloro-3-hydroxypropoxy)benzene 16a 
 
Data for 16a: 
1H NMR: (500 MHz, CDCl3) 
δ 7.31 (m, 2 H, HC(2)), 7.00 (tt, J = 7.4, 1.0 Hz, 1 H, HC(1)), 6.93 (m, 2 H, 
HC(3)), 4.23 (sext, J = 5.5 Hz, 1 H, HC(6), 4.10 (m, 2 H, H2C(5)), 3.77 (m,  
2 H, H2C(7)), 2.59 (d, J = 5.8 Hz, 1 H, OH) 
13C NMR: (126 MHz, CDCl3) 
δ 158.1 (C(4)), 129.6 (C(2)), 121.4 (C(1)), 114.5 (C(3)), 69.9 (C(5)),  
68.4 (C(6)), 46.0 (C(7)) 
IR: (neat) 
3407 (br, w), 2928 (w), 1739 (w), 1599 (m), 1588 (w), 1495 (m), 1457 (w),  
1240 (m), 1173 (w), 1078 (m), 1042 (m), 751 (s), 690 (m), 509 (m) 
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MS: (EI) 
188.0 (22, M+), 186.0 (59, M+), 144.0 (9), 142.0 (30), 137.0 (18), 119.0 (18), 
108.0 (11), 107.0 (63), 95.0 (61), 94 (100), 79.1 (20), 78.1 (13), 77.0 (69, Ph+), 
66.1 (14), 65.1 (18), 51.0 (23) 
TLC: Rf 0.22 (70:30 hexane:Et2O) [UV/CAM] 
SFC: tR 9.5 min (49.8%); tR 11.5 min (50.2%) (OD, MeOH:CO2 = 1:99 for 10 mins 
then 10:90 for 6 mins then 5:95 for 4 mins, 2.5 mL min-1, 220 nm, 40 °C) 
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Preparation of rac-1-(2-Chloro-3-hydroxypropoxy)naphthalene 16c 
 
Data for 16c: 
1H NMR: (500 MHz, CDCl3) 
δ 8.21 (d, J = 7.1 Hz, 1 H, HC(9)), 7.82 (d, J = 6.9 Hz, 1 H, HC(6)), 7.45–7.54 
(m, 3 H), HC(4), HC(7), HC(8)), 7.39 (t, J = 7.9 Hz, 1 H, HC(3)), 6.85 (d,  
J = 7.5 Hz, 1 H, HC(2)), 4.39 (sext, J = 5.5 Hz, 1 H, HC(12)), 4.28 (m, 2 H, 
H2C(11)), 3.89 (m, 2 H, H2C(13)), 2.59 (d, J = 6.1 Hz, OH) 
13C NMR: (126 MHz, CDCl3) 
δ 153.7 (C(10)), 134.5 (C(5)), 127.6 (C(6)), 126.5 (C(7)), 125.7 (C(3)),  
125.4 (C(8)), 125.3 (C(1)), 121.5 (C(9)), 121.0 (C(4)), 105.0 (C(2)), 69.9 (C(11)), 
68.6 (C(12)), 46.3 (C(13)) 
IR: (powder) 
3312 (br, w), 3056 (w), 2926 (w), 2853 (w), 1738 (w), 1627 (w), 1577 (m),  
1509 (w), 1456 (w), 1393 (m), 1322 (w), 1270 (m), 1208 (m), 1100 (m),  
1021 (m), 904 (m), 793 (m), 770 (s), 707 (m), 574 (m), 514 (w) 
MS: (EI) 
238.0 (8, M+), 236.0 (25, M+), 145.0 (13), 144.0 (100), 127.0 (10, Naph+),  
116 (15), 115 (25), 94.0 (10) 
TLC: Rf 0.17 (70:30 hexane:Et2O) [UV/CAM] 
SFC: tR 24.2 min (50.2%); tR 32.1 min (49.8%) (OD, MeOH:CO2 = 10:90,  
2.5 mL min-1, 220 nm, 40 °C) 
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Preparation of rac-4-Chloro-3-hydroxybutan-2-one 16b 
 
1-(Oxiran-2-yl)ethanone was prepared on a 2 mmol scale, according to a literature 
procedure.183 The crude, colorless oil produced in this reaction was then cooled to 0 C in a 7-mL 
vial, and CHCl3 (0.5 mL) and concentrated HCl (0.25 mL)  were added to form a colorless/yellow 
biphase. The mixture was stirred at rt for 2 h. H2O (3 mL) was added, and the organic components 
were extracted with CHCl3 (3 × 5 mL). The organic extracts were dried over CaCl2, filtered, and 
concentrated in vacuo to a crude, dark, brown oil. This complex mixture was separated via column 
chromatography using an eluent gradient from 95:5 to 80:20 hexane:ethyl acetate, to yield 71 mg 
(0.58 mmol, 29% yield over two steps) of a volatile, colorless oil 16b.  
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Data for 16b: 
1H NMR: (500 MHz, CDCl3) 
δ 4.29 (t, J = 5.6 Hz, 1 H, HC(3)), 3.92 (m, 2 H, H2C(4)), 3.02 (br s, 1 H, 
OH), 2.33 (s, 3 H, H3C(1)) 
13C NMR: (126 MHz, CDCl3) 
203.39 (C(2)), 63.42 (C(3)), 62.54 (C(4)), 27.40 (C(1)) 
IR: (neat) 
3419 (br, w), 2941 (w), 1715 (s), 1420 (m), 1358 (m), 1224 (m), 1162 (w), 
1075 (m), 1041 (m), 929 (w), 796 (w), 733 (m), 680 (m), 629 (m), 593 (m), 
559 (m), 474 (s) 
MS: (EI) 
128.0 (10), 126.0 (16), 109.1 (7.4, [M-Me]+), 107.0 (23.0, [M-Me]+),  
94.0 (12), 92.0 (37.6), 91.1 (11.9), 87.1 (20.2, [M-Cl]+), 86.1 (13.5),  
81.1 (16.3, [M-Ac]+), 79.0 (53.8, [M-Ac]+), 77.0 (17.2), 76.0 (11.2),  
71.1 (21.2), 69.1 (15.2), 64.1 (47.7), 62.1 (100), 57.2 (15.9), 55.1 (14.2) 
TLC: Rf 0.37 (70:30 hexane:EtOAc) [DNP] 
GC: tR 16.6 min (50.3%); tR 17.4 min (49.7%) (CycloSil-B, 70 °C) 
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Preparation of Racemic Dibromide Standards  
Preparation of rac-20a, rac-20b and rac-20d 
 
A 20-mL scintillation vial was charged with the requisite allylic ether 19 (0.50 mmol) and 
CH2Cl2 (1.5 mL, 0.33 M in 19). Pyridinium tribromide (88% active, 182 mg, 0.50 mmol, 1.0 equiv) 
was then added in one portion, followed by 95% ethanol (1.5 mL, 0.33 M in 19). The vial was 
capped with a plastic-lined cap, and the orange-yellow solution stirred for 24 h, during which time 
the color is lost. Reaction progress was monitored by TLC. The reaction was quenched by the 
addition of saturated aqueous Na2S2O3 solution (1.0 mL), and the mixture diluted with CH2Cl2  
(10 mL) and H2O (10 mL). The layers were separated, and the organic phase was extracted with 
CH2Cl2 (3 × 10 mL). The organic extracts were dried over MgSO4, filtered, and concentrated in 
vacuo to give racemic dibromides 20.  
Preparation of rac-1-(2,3-Dibromopropoxy)-4-Methoxybenzene (20a) 
 
Dibromide 20a was synthesized from 19a (0.3 mmol) to yield 94 mg (290 μmol,  
97% yield) of a white solid. Spectroscopic data were consistent with those of Henry.27 
Data for 20a: 
1H NMR: (500 MHz, CDCl3) 
δ 6.82–6.91 (m, 4 H, HC(2,3)), 4.38–4.44 (ABX, 1 H, HC(6)), 4.28–4.36 (ABX, 
2 H, H2C(5)), 3.86–3.95 (ABX, 2 H, H2C(7)), 3.78 (s, 3 H, H3C(8)) 
13C NMR: (126 MHz, CDCl3) 
δ 154.5 (C(1)), 152.1 (C(4)), 116.2 (C(3)), 114.7 (C(2)), 70.1 (C(5)), 55.7 (C(8)), 
48.0 (C(6)), 32.8 (C(7)) 
IR: (neat) 
2999 (w), 2932 (2), 2968 (w), 1593 (w), 1505 (s), 1456 (m), 1290 (w), 1223 (s), 
1108 (w), 1034 (m), 822 (s), 751 (m), 574 (m), 522 (w) 
73 
 
 
MS: (EI) 
325.9 (11, M+), 323.9 (20, M+), 321.9 (11, M+), 164.1 (9, [M−Br2]+), 124.1 (90), 
123.1 (100, [M−C3H5Br2]+), 109.0 (15), 95.0 (19), 62.0 (11) 
TLC: Rf 0.36 (90:10 hexane:EtOAc) [UV/CAM] 
HPLC: tR 19.6 min (49.8%); tR 21.2 min (50.2%) (OJ-H, hexane/isopropanol = 95.5:4.5, 
1.0 mL min-1, 220 nm, 20 °C) 
 
 
Preparation of 1-(2,6-Dibromopropoxy)-4-Cyanobenzene (20b) 
 
Dibromide 20b was synthesized from 19b (0.3 mmol) to yield 92 mg (288 μmol,  
96% yield) of a white solid. Spectroscopic data were consistent with those of Henry.27 
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Data for 20b: 
1H NMR: (500 MHz, CDCl3) 
δ 7.61 (d, J = 9.0 Hz, 2 H, HC(2)), 7.00 (d, J = 9.0 Hz, 2 H, HC(3)), 4.39–4.48 
(m, 3 H, H2C(5), HC(6)), 3.87–3.93 (m, 2 H, H2C(7)) 
13C NMR: (126 MHz, CDCl3) 
δ 161.1 (C(4)), 134.1 (C(2)), 118.8 (C(1)), 115.4 (C(3)), 105.1 (C(8)),  
69.2 (C(5)), 46.6 (C(6)), 32.1 (C(7)) 
IR: (powder) 
2924 (w), 2227 (m), 1904 (w), 1651 (w), 1605 (m), 1509 (m), 1453 (w),  
1302 (w), 1270 (m), 1253 (m), 1173 (m), 1119 (w), 1043 (w), 990 (w), 834 (m), 
575 (m), 546 (m) 
MS: (EI) 
320.9 (11, M+), 318.9 (22, M+), 316.9 (11, M+), 240.0 (2, [M−HBr]+),  
238.0 (2, [M−HBr]+), 202.9 (39, [M−OAryl+], 200.9 (82, [M−OAryl+],  
198.9 (42, [M−OAryl+], 120.9 (36, [M−BrOAryl]+), 119.0  
(100, [M−BrOAryl]+), 102.0 (14, [C6H4CN]+), 90.0 (8), 62.1 (45) 
TLC: Rf 0.15 (90:10 hexane:EtOAc) [AgNO3-H2O2] 
HPLC: tR 30.5 min (50.0%); tR 32.8 min (50.0%) (IB-3, hexane/isopropanol = 92:8,  
1.0 mL min-1, 220 nm, 20 °C) 
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Preparation of rac-1-(2,3-Dibromopropoxy)-2,6-Diisopropylbenzene (20d) 
 
Dibromide 20d was synthesized from 19d (0.2 mmol) to yield 73 mg (193 μmol,  
97% yield) of colorless needles. Spectroscopic data were consistent with those of Henry.27 
Data for 19d:  
1H NMR: (500 MHz, CDCl3) 
δ 7.09–7.13 (m, 3 H, HC(1,2)), 4.45 (ABX, 1 H, HC(8)), 4.15 (ABX, 2 H, 
H2C(7)), 3.96 (ABX, 2 H, H2C(9)), 3.42 (sept, J = 6.8 Hz, 2 H, HC(5)),  
1.24 (d, J = 6.8 Hz, 12 H, H3C(6)) 
13C NMR: (126 MHz, CDCl3) 
δ 151.7 (C(4)), 141.9 (C(3)), 125.2 (C(2)), 124.1 (C(1)), 74.1 (C(7)), 48.6 (C(8)), 
32.3 (C(9)), 26.3 (C(5)), 24.1 (C(6)) 
IR: (neat) 
2962 (w), 2927 (w), 2868 (w), 1589 (w), 1457 (w), 1442 (w), 1328 (w), 1256 (w), 
1180 (m), 1035 (w), 981 (w), 914 (w), 799 (w), 759 (m), 577 (m) 
MS: (EI) 
380.0 (11, M+), 378.0 (22, M+), 376.0 (11, M+), 218.2 (5), 202.9 (6, [M−Aryl]+), 
200.9 (12, [M−Aryl]+), 198.9 (6, [M−Aryl]+), 178.1 (100, [M−C3H4Br2]+),  
163.1 (92), 147.1 (10), 135.1 (47), 121.0 (12), 107.1 (13), 91.1 (17), 77.1 (7),  
62.1 (6) 
TLC: Rf 0.60 (90:10 hexane:EtOAc) [UV/CAM] 
HPLC: tR 12.5 min (49.7%); tR 13.9 min (50.3%) (IB-3, hexane/isopropanol = 99.9:0.1, 
1.0 mL min-1, 220 nm, 20 °C) 
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Preparation of rac-(2,3-Dibromopropoxy)benzene (20c) 
 
Dibromide 20c was prepared according to a literature procedure, and had spectroscopic 
data consistent with the literature.184  
Data for 20c: 
1H NMR: (500 MHz, CDCl3) 
δ 7.31 (dd, J = 8.5, 7.5 Hz, 2 H, HC(2)), 7.00 (t, J = 7.4 Hz, 1 H, HC(1)), 6.94 (d, 
J = 7.9 Hz, 2 H, HC(3)), 4.35–4.47 (m, 3 H, H2C(6), HC(7)), 3.88–3.96 (m, 2 H, 
H2C(8)) 
13C NMR: (126 MHz, CDCl3) 
δ 157.9 (C(4)), 129.6 (C(2)), 121.7 (C(1)), 114.8 (C(3)), 69.0 (C(5)), 47.7 (C(6)), 
32.8 (C(7)) 
IR: (neat) 
2927 (w), 2869 (w), 1598 (m), 1495 (m), 1240 (m), 1047 (w), 908 (w), 884 (w), 
814 (w), 752 (s), 690 (m), 509 (w) 
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MS: (EI) 
295.9 (10, M+), 293.9 (21, M+), 291.9 (11, M+), 202.9 (6, [M−OPh]+),  
200.9 (13, [M−OPh]+), 198.9 (7, [M−OPh]+), 121.0 (14, [M−BrOPh]+),  
119.0 (14, [M−BrOPh]+), 95.0 (11), 94.0 (100), 77.1 (16.9, Ph+), 65.1 (13) 
TLC: Rf 0.78 (90:10 hexane:Et2O) [UV/CAM] 
SFC: tR 6.3 min (49.8%); tR 6.6 min (50.2%) (OD, MeOH:CO2 = 3:97, 2.5 mL min
-1, 
220 nm, 40 °C) 
 
 
Conditions and Spectra for Dibromination Reactions:  
Reactions were run according to Henry’s procedures.27 The procedures were all reproduced 
as rigorously as the described procedures allow, other than changing the scale and reaction time – 
with the exception of Run 3, which was reproduced exactly. Reaction progress was monitored by 
TLC. Concentrations are calculated with respect to total solvent volume.  
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Table 10. Conditions for Dibromination Reactions 
Run Product Scale,  
mmol 
Pd 
complex, 
mol % 
CuBr2 
equiv 
CuBr2 
molarity, 
M 
LiBr 
equiv 
LiBr 
molarity, 
M 
THF/H2O 
ratio 
Time, 
h 
1 20a† 0.25 2.3 13.74 2.0 M 1.75 0.26 M 17:3 28 
2 20a† 0.25 2.3 13.74 2.0 M 1.75 0.26 M 17:3 28 
3 20a† 3.0 2.3 13.73 2.1 M 1.73 0.26 M 17:3 144 
4 20a† 0.25 2.3 13.75 2.1 M 1.75 0.27 M 17:3 6 
5 20b 0.25 2.4 15.83 2.0 M 1.01 0.13 M 1:9 24 
6 20c 0.25 1.4 10.65 2.0 M 1.11 0.20 M 17:3 24 
7 20d 0.25 2.5 15.83 2.2 M 1.24 0.17 M 87:13 24 
† Nuclearity of palladium(II) catalyst is ambiguous in the original report for dibromination of 19a.  
Run 1: Dibromination of 19a with Henry’s catalyst preparation, 0.25 mmol, 28 h† 
 
A 25-mL, round-bottomed flask containing a Teflon-coated, magnetic stir bar was charged 
with (R)-BINAP 18,† freshly prepared according to Henry’s method (7.5 mg, 5.8 μmol,  
2.3 mol %), and weighed out in a glovebox. The system was sealed under Ar, and removed from 
the glovebox, then an Ar line inserted, and 17:3 THF:H2O (1.0 mL) injected to give a yellow 
solution. Then, copper(II) bromide (767 mg, 3.43 mmol, 13.74 equiv, 2.0 M) was added in one 
portion to form a deep green solution, followed by lithium bromide (38 mg, 0.43 mmol, 1.73 equiv, 
0.26 M) in one portion, which gave slight yellowing of the solution. The atmosphere was replaced 
with 1 atm O2 by sparging, and the reaction run under 1 atm O2 from an oxygen manifold. 19a  
(41 mg, 0.25 mmol) was then added to the mixture, washing with 17:3 THF:H2O (0.7 mL). The 
mixture was left to stir at rt, monitoring periodically by TLC. Completion was reached at 28 h, and 
the mixture was extracted with CH2Cl2 (3 × 20 mL), then dried over MgSO4. Hexane (5 mL) was 
added, and the precipitated orange Pd complex removed by filtration, washing with hexane  
(3 × 5 mL). Solvent was removed in vacuo, then the mixture purified via column chromatography 
using 93:7 hexane:ethyl acetate as eluent, to yield dibromide 20a as a white solid, 70 mg  
(0.22 mmol, 86% yield). This was found to be racemic by CSP-HPLC. 1H NMR spectroscopic 
data were identical to those of the racemic standard. 
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Data for 20a:  
HPLC: tR 19.5 min (50.1%); tR 21.0 min (49.9%) (OJ-H, hexane/isopropanol = 95.5:4.5, 1.0 
mL min-1, 220 nm, 20 °C) 
 
 
80 
 
 
 
 
Run 2: Dibromination of 19a with New Catalyst Preparation, 0.25 mmol, 28 h† 
 
Run 1 was replicated, with the exception of using catalyst (R)-BINAP 18 prepared by the 
new method described above. Dibromide 20a was produced as a white solid, 69 mg (0.21 mmol, 
85% yield). This was found to be racemic by CSP-HPLC. 1H NMR spectroscopic data were 
identical to those of the racemic standard. 
Data for 20a:  
HPLC: tR 19.0 min (50.0%); tR 21.0 min (50.0%) (OJ-H, hexane/isopropanol = 95.5:4.5,  
1.0 mL min-1, 220 nm, 20 °C) 
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Run 3: Dibromination of 19a, 3.00 mmol, 6 days† 
 
An oven-dried, 50-mL, round-bottomed flask containing a Teflon-coated, magnetic stir bar 
was charged with tetrakis(acetonitrile)palladium(II) tetrafluoroborate (31 mg, 69 mol,  
2.3 mol %) and (R)-2,2-bis(diphenylphosphino)-1,1-binaphthyl ((R)-BINAP) (43 mg, 69 mol, 
2.3 mol %) in a glovebox. The system was sealed under Ar, and removed from the glovebox, then 
an Ar line inserted, and 17:3 THF:H2O (15 mL) injected. The solution was stirred at rt for 10 min, 
and turned from light to dark orange color. Then, copper(II) bromide (9.20 g, 41.2 mmol,  
13.73 equiv, 2.1 M) was added in one portion to form a deep green solution, followed by lithium 
bromide (450 mg, 5.2 mmol, 1.73 equiv, 0.26 M) in one portion, which gave slight yellowing of 
the solution. The atmosphere was replaced with 1 atm O2 by sparging, and the reaction run under 
1 atm O2 from an oxygen manifold. 19a (493 mg, 3.00 mmol) was then added to the mixture, 
washing with 17:3 THF:H2O (5 mL). The mixture was left to stir at rt. After 6 days, the mixture 
was extracted with CH2Cl2 (3 × 50 mL), then dried over MgSO4. Hexane (15 mL) was added, and 
the precipitated orange Pd complex removed by filtration, washing with hexane (3 × 10 mL). 
Solvent was removed in vacuo, then the mixture purified via column chromatography using  
95:5 hexane:ethyl acetate as eluent, to yield dibromide 20a, 754 mg (2.33 mmol, 78% yield) of a 
white solid. This was found to be racemic by CSP-HPLC. 1H NMR spectroscopic data were 
identical to those of the racemic standard.  
Data for 20a:  
HPLC: tR 18.7 min (49.9%); tR 20.1 min (50.1%) (OJ-H, hexane/isopropanol = 95.5:4.5, 1.0 
mL min-1, 220 nm, 20 °C) 
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Run 4: Dibromination of 19a, 0.25 mmol, 6 h† 
 
An oven-dried, 15-mL, round-bottomed flask containing a Teflon-coated, magnetic stir bar 
was charged with tetrakis(acetonitrile)palladium(II) tetrafluoroborate (2.6 mg, 5.7 mol, 2.3 mol 
%) and (R)-2,2-bis(diphenylphosphino)-1,1-binaphthyl ((R)-BINAP) (3.6 mg, 5.7 mol, 2.3 mol 
%) in a glovebox. The system was sealed under Ar, and removed from the glovebox, then an Ar 
line inserted, and 17:3 THF:H2O (1.0 mL) injected. The solution was stirred at rt for 10 min, and 
turned from light to dark orange color. Then, copper(II) bromide (758 mg, 3.43 mmol, 13.75 equiv, 
2.1 M) was added in one portion to form a deep green solution, followed by lithium bromide  
(38 mg, 0.43 mmol, 1.75 equiv, 0.27 M) in one portion, which gave slight yellowing of the 
solution. The atmosphere was replaced with 1 atm O2 by sparging, and the reaction run under  
1 atm O2 from an oxygen manifold. 19a (41 mg, 0.25 mmol) was then added to the mixture, 
washing with 17:3 THF:H2O (0.6 mL). The mixture was left to stir at rt, and stopped after 6 h. The 
mixture was extracted with CH2Cl2 (3 × 15 mL), then dried over MgSO4. Hexane (5 mL) was 
added, and the precipitated orange Pd complex removed by filtration, washing with hexane  
(3 × 5 mL). Solvent was removed in vacuo, then the mixture purified via column chromatography 
using 93:7 hexane:ethyl acetate as eluent, to yield dibromide 20a, 54 mg (0.17 mmol, 67% yield) 
as a white solid. This was found to be racemic by CSP-HPLC. 1H NMR spectroscopic data were 
identical to those of the racemic standard.  
Data for 20a: 
HPLC: tR 19.6 min (50.3%); tR 21.1 min (49.7%) (OJ-H, hexane/isopropanol = 95.5:4.5, 1.0 
mL min-1, 220 nm, 20 °C) 
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Run 5: Dibromination of 19b, 0.25 mmol, 24 h 
 
A 25-mL, round-bottomed flask containing a Teflon-coated, magnetic stir bar was charged 
with freshly-prepared (R)-Tol-BINAP 18 (8.1 mg, 6.0 μmol, 2.4 mol %), weighed out in a 
glovebox. The system was sealed under Ar, and removed from the glovebox, then an Ar line 
inserted, and 9:1 THF:H2O (1.0 mL) injected. Then, copper(II) bromide (884 mg, 3.96 mmol, 
15.83 equiv, 2.0 M) was added in one portion to form a deep green solution, followed by lithium 
bromide (22 mg, 0.26 mmol, 1.03 equiv, 0.13 M) in one portion, which gave slight yellowing of 
the solution. The atmosphere was replaced with 1 atm O2 by sparging, and the reaction run under 
1 atm O2 from an oxygen manifold. 19b (40 mg, 0.25 mmol) was then added to the mixture, 
washing with 9:1 THF:H2O (1.0 mL). The mixture was left to stir at rt, monitoring periodically by 
TLC. Completion was reached at 24 h, and the mixture was extracted with CH2Cl2 (3 × 20 mL), 
then dried over MgSO4. Hexane (5 mL) was added, and the precipitated yellow Pd complex 
removed by filtration, washing with hexane (3 × 5 mL). Solvent was removed in vacuo, then the 
mixture purified via column chromatography using 9:1 hexane:ethyl acetate as eluent, to yield 
dibromide 20b as a white solid, 68 mg (0.21 mmol, 85% yield). This was found to be racemic by 
CSP-HPLC. 1H NMR spectroscopic data were identical to those of the racemic standard. 
Data for 20b:  
HPLC: tR 30.3 min (49.8%); tR 32.6 min (50.2%) (IB-3, hexane/isopropanol = 92:8, 1.0 mL 
min-1, 220 nm, 20 °C) 
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Run 6: Dibromination of 19c, 0.25 mmol, 24 h 
 
A 25-mL, round-bottomed flask containing a Teflon-coated, magnetic stir bar was charged 
with (R)-BINAP 18, freshly prepared according to the new procedure described above (4.4 mg, 
3.4 μmol, 1.4 mol %), and weighed out in a glovebox. The system was sealed under Ar, and 
removed from the glovebox, then an Ar line inserted, and 17:3 THF:H2O (1.0 mL) injected. Then, 
copper(II) bromide (595 mg, 2.66 mmol, 10.65 equiv, 2.0 M) was added in one portion to form a 
deep green solution, followed by lithium bromide (24 mg, 0.27 mmol, 1.09 equiv, 0.20 M) in one 
portion, which gave slight yellowing of the solution. The atmosphere was replaced with 1 atm O2 
by sparging, and the reaction run under 1 atm O2 from an oxygen manifold. 19c (34 mg,  
0.25 mmol) was then added to the mixture, washing with 17:3 THF:H2O (0.35 mL). The mixture 
was left to stir at rt, monitoring periodically by TLC. Completion was reached at 24 h, and the 
mixture was extracted with CH2Cl2 (3 × 20 mL), then dried over MgSO4. Hexane (5 mL) was 
added, and the precipitated orange Pd complex removed by filtration, washing with hexane  
(3 × 5 mL). Solvent was removed in vacuo, then the mixture purified via column chromatography 
using hexane as eluent, to yield dibromide 20c as a pale yellow oil, 51 mg (0.17 mmol, 69% yield). 
This was found to be racemic by CSP-SFC. 1H NMR spectroscopic data were identical to those of 
the racemic standard. 
Data for 20c:  
SFC: tR 6.3 min (49.9%); tR 6.6 min (50.1%) (OD, MeOH:CO2 = 3:97, 2.5 mL min
-1, 220 
nm, 40 °C) 
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Run 7: Dibromination of 19d, 0.25 mmol, 24 h 
 
A 25-mL, round-bottomed flask containing a Teflon-coated, magnetic stir bar was charged 
with freshly-prepared (R)-BINAP 15 (6.2 mg, 6.3 μmol, 2.5 mol %), weighed out in a glovebox. 
The system was sealed under Ar, and removed from the glovebox, then an Ar line inserted, and 
87:13 THF:H2O (1.0 mL) injected to give a bright yellow solution. Then, copper(II) bromide  
(884 mg, 3.96 mmol, 15.83 equiv, 2.2 M) was added in one portion to form a deep green solution, 
followed by lithium bromide (27 mg, 0.31 mmol, 1.23 equiv, 0.17 M) in one portion, which gave 
slight yellowing of the solution. The atmosphere was replaced with 1 atm O2 by sparging, and the 
reaction run under 1 atm O2 from an oxygen manifold. 19d (55 mg, 0.25 mmol) was then added to 
the mixture, washing with 87:13 THF:H2O (0.8 mL). The mixture was left to stir at rt, monitoring 
periodically by TLC. Completion was reached at 24 h, and the mixture was extracted with CH2Cl2 
(3 × 20 mL), then dried over MgSO4. Hexane (5 mL) was added, and the precipitated yellow  
Pd complex removed by filtration, washing with hexane (3 × 5 mL). Solvent was removed in 
vacuo, then the mixture purified via column chromatography using 99:1 hexane:ethyl acetate as 
eluent, to yield dibromide 20d as colorless needles,  85 mg (0.22 mmol, 90% yield). This was 
found to be racemic by CSP-HPLC. 1H NMR spectroscopic data were identical to those of the 
racemic standard. 
Data for 20d:  
HPLC: tR 12.8 min (49.9 %); tR 13.6 min (50.1%) (IB-3, hexane/isopropanol = 99.9:0.1, 1.0 
mL min-1, 220 nm, 20 °C) 
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Conditions and Spectra for Chlorohydroxylation Reactions:  
Reactions were run according to Henry’s procedures.25 The procedures were all reproduced 
as rigorously as the described procedures allow, other than changing the scale. Reaction progress 
was monitored by 1H NMR of aliquots. Concentrations are calculated with respect to total solvent 
volume.  
Table 11. Conditions for Chlorohydroxylation Reactions 
Run Product Scale,  
mmol 
Pd 
complex, 
mol % 
CuCl2 
equiv 
CuCl2 
molarity, 
M 
LiCl 
equiv 
LiCl 
molarity, 
M 
THF/H2O Time, 
days 
8 16a 0.5 2.5 20.00 4.0 1.00 0.20 2:1 14 
9 16a 0.5 1.2 14.59 1.8 2.43 0.30 92:8 5 
10 16b 1.0 1.0 8.00 8.0 0.40 0.40 2:1 10 
11 16c 0.5 1.5 13.38 2.9 0.92 0.20 90:10 10 
 
Run 8: Chlorohydroxylation of 19c with (R)-Tol-BINAP 15, 0.50 mmol, 14 days 
 
In a glovebox, a 10-mL, two-necked flask containing a Teflon-coated, magnetic stir bar 
was charged with bis(acetonitrile)dichloropalladium(II) (3.2 mg, 12 μmol, 2.5 mol %). The flask 
was sealed under Ar and removed from the glovebox. An Ar line was inserted, and anhydrous THF 
(1.0 mL) was injected. (R)-Tol-BINAP (9.5 mg, 14 μmol, 2.9 mol %) was added to form a yellow 
solution, which was stirred at rt for 30 min. Then, a separate 10-mL, round-bottomed flask 
containing a Teflon-coated, magnetic stir bar was charged with anhydrous copper(II) chloride 
(1.344 g, 10.0 mmol, 20.0 equiv) and lithium chloride (21 mg, 0.5 mmol, 1.00 equiv), and  
45:55 THF/H2O (0.5 mL) was added to form a green solution. The catalyst solution was cannulated 
into the second flask, washing with 45:55 THF/H2O (0.5 mL). The atmosphere was replaced with 
1 atm O2 by sparging, and the reaction run under 1 atm O2 from an oxygen manifold. 19c (67 mg, 
0.5 mmol) was then added to the mixture, washing with 45:55 THF/H2O (0.5 mL). The eventual 
solvent mixture was 2:1 THF/H2O. The mixture was left to stir at rt, monitoring periodically by 
NMR spectroscopy of aliquots. Despite low conversion, the reaction was stopped after 14 days. 
H2O (10 mL) was added, and the mixture was extracted with CH2Cl2 (3 × 10 mL), then dried over 
CaCl2. Solvent was removed in vacuo, then the mixture purified via column chromatography using 
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a gradient from 93:7 to 85:15 hexane:ethyl acetate as eluent, to yield chlorohydrin 16a as a pale 
yellow oil, 14 mg (0.075 mmol, 15% yield). This was found to be racemic by CSP-SFC. 1H NMR 
spectroscopic data were identical to those of the racemic standard. 
Data for 16a:  
SFC: tR 9.8 min (49.5%); tR 11.7 min (50.5%) (OD, MeOH:CO2 = 1:99 for 10 mins then 
10:90 for 6 mins then 5:95 for 4 mins, 2.5 mL min-1, 220 nm, 40 °C) 
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Run 9: Chlorohydroxylation of 19c with (R)-BINAP 18, 0.50 mmol, 5 days 
 
In a glovebox, a 10-mL, two-necked flask containing a Teflon-coated, magnetic stir bar 
was charged with (R)-BINAP 18, freshly prepared according to Henry’s method (7.9 mg,  
6.1 μmol, 1.2 mol %). The flask was sealed under Ar and removed from the glovebox. An Ar line 
was inserted, and anhydrous THF (1.0 mL) was injected. Anhydrous copper(II) chloride (981 mg, 
7.30 mmol, 14.59 equiv) and lithium chloride (52 mg, 1.21 mmol, 2.43 equiv) were then added, 
followed by 89:11 THF:H2O (2.05 mL), to form a green solution. The atmosphere was replaced 
with 1 atm O2 by sparging, and the reaction run under 1 atm O2 from an oxygen manifold. 19c  
(67 mg, 0.5 mmol) was then added to the mixture, washing with 92:8 THF:H2O (1.0 mL). The 
eventual solvent mixture was 92:8 THF:H2O. The mixture was left to stir at rt, monitoring 
periodically by NMR spectroscopy of aliquots, and stopped after 5 days. H2O (10 mL) was added, 
and the mixture was extracted with CH2Cl2 (3 × 10 mL), then dried over CaCl2. Solvent was 
removed in vacuo, then the mixture purified via column chromatography using a gradient from 
93:7 to 85:15 hexane:ethyl acetate as eluent, to yield chlorohydrin 16a as a pale yellow oil, 37 mg 
(0.20 mmol, 40% yield). This was found to be racemic by CSP-SFC. 1H NMR spectroscopic data 
were identical to those of the racemic standard. 
Data for 16a:  
SFC: tR 9.7 min (49.5%); tR 11.6 min (50.5%) (OD, MeOH:CO2 = 1:99 for 10 mins then 
10:90 for 6 mins then 5:95 for 4 mins, 2.5 mL min-1, 220 nm, 40 °C) 
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Run 10: Chlorohydroxylation of 19e with (R)-Tol-BINAP 14, 1.00 mmol, 10 days 
 
In a glovebox, a 10-mL, two-necked flask containing a Teflon-coated, magnetic stir bar 
was charged with bis(acetonitrile)dichloropalladium(II) (2.6 mg, 10 μmol, 1.0 mol %). The flask 
was sealed under Ar and removed from the glovebox. An Ar line was inserted, and anhydrous THF 
(1.0 mL) was injected. (R)-Tol-BINAP (9.9 mg, 15 μmol, 1.5 mol %) was added to form a yellow 
solution, which was stirred at rt for 30 min. Then, a separate 10-mL, round-bottomed flask 
containing a Teflon-coated, magnetic stir bar was charged with anhydrous copper(II) chloride 
(1.076 g, 8.0 mmol, 8.0 equiv) and lithium chloride (17 mg, 0.4 mmol, 0.4 equiv), then  
1:2 THF\H2O (0.3 mL) was added to form a green solution. The catalyst solution was cannulated 
into the second flask, washing with 1:2 THF\H2O (0.3 mL). The atmosphere was replaced with 1 
atm O2 by sparging, and the reaction run under 1 atm O2 from an oxygen manifold. Methyl vinyl 
ketone 19e (70 mg, 1.0 mmol) was then injected into the mixture, washing with 1:2 THF\H2O (0.4 
mL). The eventual solvent mixture was 2:1 THF\H2O. The mixture was left to stir at rt, monitoring 
periodically by NMR spectroscopy of aliquots, and stopped after 10 days. H2O  
(10 mL) was added, and the mixture was extracted with CH2Cl2 (3 × 10 mL), then dried over 
CaCl2. Solvent was removed in vacuo, then the mixture purified via column chromatography using 
a gradient from 95:5 to 80:20 hexane:ethyl acetate as eluent, to yield chlorohydrin 16b as a 
colorless oil, 40 mg (0.33 mmol, 33% yield). This was found to be racemic by CSP-GC. 1H NMR 
spectroscopic data were identical to those of the racemic standard. 
Data for 16b:  
GC: tR 16.9 min (50.3%); tR 17.7 min (49.7%) (CycloSil-B, 70 °C) 
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Run 11: Chlorohydroxylation of 19f with (R)-BINAP 18, 0.50 mmol, 14 days 
 
NOTE: The major product was mischaracterized in Henry and coworkers’ original report.25 The 
product there characterized was present in small amounts (roughly 9%) in the crude reaction 
mixture and is proposed to be the constitutionally isomeric chlorohydroxylation product.   
In a glovebox, a 10-mL, two-necked flask containing a Teflon-coated, magnetic stir bFar 
was charged with (R)-BINAP 18, freshly prepared according to Henry’s method (9.9 mg,  
7.7 μmol, 1.5 mol %). The flask was sealed under Ar and removed from the glovebox. An Ar line 
was inserted, and anhydrous THF (1.0 mL) was injected. Anhydrous copper(II) chloride (900 mg, 
6.69 mmol, 13.38 equiv) and lithium chloride (20 mg, 0.46 mmol, 0.92 equiv) were then added, 
followed by 82:18 THF:H2O (0.7 mL), to form a green solution. The atmosphere was replaced 
with 1 atm O2 by sparging, and the reaction run under 1 atm O2 from an oxygen manifold. 19f  
(92 mg, 0.5 mmol) was then added to the mixture, washing with 82:18 THF:H2O (0.6 mL). The 
eventual solvent mixture was 90:10 THF:H2O. The mixture was left to stir at rt, monitoring 
periodically by NMR spectroscopy of aliquots. Despite incomplete conversion, the reaction was 
stopped after 10 days. H2O (10 mL) was added, and the mixture was extracted with CH2Cl2  
(3 × 10 mL), then dried over CaCl2. Solvent was removed in vacuo, then the mixture purified via 
column chromatography using a gradient from 90:10 to 30:70 hexane:Et2O as eluent, to yield 
firstly recovered 54 mg of pink solid 19f (0.29 mmol, 59% yield of recovered starting material), 
and secondly chlorohydrin 16c as a pale yellow oil, 34 mg (0.14 mmol, 29% yield). This was 
found to be racemic by CSP-SFC. 1H NMR spectroscopic data were identical to those of the 
racemic standard. 
Data for 16c:  
SFC: tR 24.6 min (50.1%); tR 32.7 min (49.9%) (OD, MeOH:CO2 = 10:90, 2.5 mL min
-1, 
220 nm, 40 °C) 
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Chiral Shift NMR Experiment 
CDCl3 was purified by passing through a dry neutral Al2O3 column (70 × 7 mm diameter). 
Eu(hfc)3 (448 mg, 375 µmol) was dissolved in 2.0 mL of this purified CDCl3, and the bright yellow 
solution filtered through a Celite column (25 × 6 mm diameter) with a slight positive Ar flow. 
Dibromide 20a (40.5 mg, 125 µmol) was dissolved in purified CDCl3 (0.5 mL) in an NMR tube. 
The Eu(hfc)3 solution was added portionwise to the solution of 20a, and 
1H NMR spectra  
(400 MHz) were recorded after each subsequent addition. The spectrum corresponding to 4 equiv 
Eu(hfc)3 was taken in CDCl3 (0.8 mL), containing 20a (23.8 mg, 70 µmol) and Eu(hfc)3 (334 mg, 
280 µmol). The processing parameters for this spectrum were:  
Spectrometer frequency 400 MHz 
Delay time 10 s 
Number of scans 16 
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EXPERIMENTAL PROCEDURES: CHAPTER 2 
General Procedure 1: Hiyama-Denmark Reaction for the Synthesis of 4-Methoxy-1,1’:2’,1’’-
Terphenyl 21b  
 
Ligand (100 μmol, 5 mol %), Pd source (100 μmol, 5 mol %) and 24 (40 mg, 150 μmol, 
1.5 equiv) were added sequentially to a flame-dried, 5-mL vial in a glovebox, and the vial sealed 
under Ar and removed from the glovebox. n-Tetradecane (26 μL, 20 mg, 0.1 mmol) was then 
added as an internal GC standard, followed by 4-bromoanisole (12.5 μL, 18.7 mg, 0.1 mmol), and 
anhydrous toluene (1 mL). The vial was placed in a sand bath (preheated to temperature), and 
stirred under an Ar blanket. At the required times, 50 μL aliquots were removed and quenched by 
addition to 1 mL brine, and the organic phase was extracted with EtOAc (1.5 mL) in a vial, and 
the organics removed via pipette and filtered through a silica plug.   
Preparation of (2-Bromophenyl)dimethylsilane 29 
 
LiCl (2.395 g, 56.5 mmol, 1.13 equiv) was added to a three-necked, 250-mL, round-
bottomed flask, equipped with a gas adapter, a septum, and a stopper, in a glovebox. The apparatus 
was removed from the glovebox and flame-dried in vacuo (85 Pa), then back-filled with argon and 
cooled to rt. i-PrMgCl (1.86 M in THF, 30 mL, 55 mmol, 1.1 equiv) was added, and the 
heterogeneous brown mixture stirred at rt for 15 min.  The reaction was cooled to −15 °C, then 
1,2-dibromobenzene (6.03 mL, 11.8 g, 50 mmol) was added dropwise over 7 min.  The reaction 
was then stirred at −15 °C for 2 h.  A solution of chloro(dimethyl)silane (5.55 mL, 4.73 g,  
50.0 mmol, 1.0 equiv) in THF (anhydrous, 60 mL, 0.83 M in Me2HSiCl) in a two-necked, round-
bottomed flask under Ar was then transferred into the reaction dropwise over 22 min, via cannula.  
The cloudy brown suspension was stirred for 15 min at −15 °C, then warmed to rt and stirred for 
a further 1 h. At this point, the reaction was quenched with H2O (120 mL), and the organic 
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components extracted with CH2Cl2 (3 × 100 mL), and washed with H2O (100 mL).  The organic 
layer was dried (MgSO4) and concentrated in vacuo.  The crude yellow oil was purified by column 
chromatography, using hexane as eluent, to give 9.971 g (93%) of the title product as a colorless 
oil. Spectral data matched the literature.185  
Additional data for 29: 
bp: 58 °C (ABT), 67 Pa 
TLC: hexane (UV/I2): Rf = 0.57 
 
Preparation of (2-Bromophenyl)dimethylsilanol 30 
 
To a solution of silane 29 (2.28 g, 10.6 mmol, 1.0 equiv) in MeCN (anhydrous, 10 mL) in 
a flame-dried, 25-mL recovery flask was added [Ir(cod)Cl]2 (36 mg, 0.053 mmol, 0.5 mol %).  
H2O (955 µL, 53 mmol, 5 equiv) was added dropwise, and reaction loosely capped. Vigorous H2 
evolution was observed. The clear, yellow mixture was stirred for 30 min at rt, accompanied by a 
slight color change to yellow-orange.  The mixture was poured into brine (10 mL), and extracted 
with Et2O (3 × 10 mL).  The organic layer was dried (MgSO4) and concentrated in vacuo.  The 
crude, cloudy yellow oil was purified via Kugelrohr distillation (100 °C, 13 Pa) to 1.78 g (83%) 
of the title compound as a colorless oil. Spectral data matched the literature.186  
NB: silanol 30 is unstable in the presence of acid (including SiO2) or base, to the disiloxane, 
which may be hydrolysed to 30 in 77% yield by the method of Fleming.187 Data for the disiloxane 
is included below for comparison.  
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Additional data for silanol 30: 
1H NMR: (400 MHz, CDCl3) 
δ 7.54 (m, 2 H, HC(3), HC(6)), 7.32 (td, J = 7.3 Hz, 1.2 Hz, 1 H, HC(5)), 7.24 (td, 
J = 7.5 Hz, 1.9 Hz, 1 H, HC(4)), 2.24 (br s, 1 H, OH), 0.52 (s, 6H, H3C(7)) 
13C NMR: (126 MHz, CDCl3) 
140.26 (C(1)), 135.91 (C(6)), 132.53 (C(4)), 131.35 (C(3)), 129.13 (C(2)), 126.65 
(C(5)), 0.39 (C(7)) 
bp: 100 °C (ABT), 13 Pa 
TLC: basic Al2O3, 9:1 hexane/EtOAc (UV/I2): Rf = 0.32 
 
 
Data for disiloxane of 30: 
1H NMR: (500 MHz, CDCl3) 
δ 7.61 (dd, 1 H, J = 7.3, 1.9 Hz, HC(4)), 7.53 (dd, 1 H, J = 7.9, 1.0 Hz, HC(3)), 
7.29 (td, 1 H, J = 7.3, 1.1 Hz, HC(5)), 7.24 (td, 1 H, J = 7.7, 1.9 Hz, HC(6)), 0.53 
(s, 6 H, H3C(7)) 
13C NMR: (126 MHz, CDCl3) 
δ 140.65 (C(1)), 136.29 (C(6)), 132.65 (C(4)), 131.12 (C(3)), 129.05 (C(2)), 126.43 
(C(5)), 1.56 (C(7)) 
MS: (EI-LRMS) 
426.9 (M−Me)+ 
TLC: basic Al2O3, 9:1 hexane/EtOAc (UV/I2): Rf = 0.82 
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Preparation of 1,3-Dihydro-3-hydroxy-1,1-dimethyl-1,2,3-benzosiloxaborole 31 
 
NB: Fast warming to rt over about 9 min is necessary to avoid decomposition. On smaller scale 
(0.5 mmol of 30), this occurred without the aid of a warm water bath.  
A Schlenk flask under Ar was charged with NaH (160 mg, 6.65 mmol, 1.2 equiv), followed 
by THF (anhydrous, 2 mL).  The white suspension was cooled to 0 °C, then a solution of 30  
(1.28 g, 5.54 mmol) in THF (anhydrous, 2 mL) was added, dropwise.  Vigorous H2 evolution was 
observed. The mixture was allowed to warm to rt, and stirred for 30 min. Then, the mixture was 
diluted with PhMe (anhydrous, 6 mL), and cooled to −78 °C. n-BuLi (2.47 M in hexane, 2.69 mL, 
6.65 mmol, 1.2 equiv) was added dropwise, and now clear, yellow solution stirred for 1 h at  
−78 °C. B(Oi-Pr)3 (1.53 mL, 6.65 mmol, 1.2 equiv) was added dropwise, and the reaction warmed 
quickly in a 40 °C bath to rt over 9 min, turning cloudy white. The suspension was cooled to 0 °C 
in an ice bath, and opened to air. The mixture was acidified to pH 1 with HCl (1 N, 2.5 mL, checked 
with pH paper), forming a bright, clear, yellow organic layer and a faint pink aqueous layer. This 
biphase was stirred vigorously at rt for 30 min. The organic components were extracted with Et2O 
(3 × 15 mL), then dried (MgSO4) and concentrated in vacuo to 883 mg crude, off-white solid  
(82% on the basis of 31).  The crude mixture of 31, its isopropyl boronate ester, and the boronic 
anhydride was used without further purification. Spectral data for 31 matched the literature.185  
Additional data for 31: 
TLC: 9:1 hexane/EtOAc (UV/CAM): Rf = 0.64 
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Preparation of Potassium 3,3-Difluoro-1,3-dihydro-1,1-dimethyl-1,2,3-benzosiloxaborolate 
24 
 
CAUTION! THIS REACTION GENERATES HIGHLY TOXIC HYDROGEN FLUORIDE 
(HF). USE PLASTIC VESSELS.  
The crude mixture containing siloxaborolol 31 (1.02 g, 5.72 mmol based on 31) was 
dissolved in MeOH (10 mL) in a round-bottomed, 100-mL, Teflon flask. A solution of KHF2  
(470 mg, 6.01 mmol, 1.05 equiv) in H2O (3 mL) was added to the mixture, dropwise.  The reaction 
was stirred at rt for 30 min, and then solvent removed in vacuo.  The residue was extracted with rt 
acetone (2 × 5 mL), then hot acetone (2 × 5 mL).  The organic extracts were filtered through a pad 
of CaCO3 (10 × 40 mm diameter), and concentrated in vacuo at 50 °C, azeotropic H2O with PhMe, 
to a white solid. This mixture was purified via Soxhlet extraction with anhydrous TBME for  
4 days. If any of the ring-opened trifluoroboryl silyl fluoride impurity remains, washing the 
material repeatedly with boiling, anhydrous Et2O under an Ar funnel will afford the pure product. 
The title compound was thus isolated as 846 mg white solid (62%).  
NB: running the reaction for too long will result in increased side-product formation. 
Spectral data for the trifluoroboryl silyl fluoride side-product matched the literature.185  
Data for 24: 
1H NMR: (500 MHz, d6-DMSO) 
δ 7.25 (d, J = 7.0 Hz, 1 H, HC(2)), 7.22 (d, J = 7.2 Hz, 1 H, HC(5)), 7.07 (td,  
J = 7.2 Hz, 1.3 Hz, 1 H, HC(3)), 6.98 (td, J = 7.2 Hz, 1.2 Hz, 1 H, HC(4)),  
0.10 (s, 1 H, H3C(7)) 
13C NMR: (126 MHz, d6-DMSO) 
δ 128.8 (C(2)), 128.1 (C(5)), 127.1 (C(4)), 124.6 (C(3)), 1.61 (H3C(7)) 
(126 MHz, CD3CN) 
δ 130.4 (C(2)), 129.4 (C(5)), 128.9 (C(4)), 126.6 (C(3)), 1.21 (H3C(7), under 
solvent signal) 
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19F NMR: (376 MHz, d6-DMSO) 
δ −138.4 (m) 
(376 MHz, CD3CN) 
δ −138.2, −138.3, −138.5, −138.6 
11B NMR: (128 MHz, CD3CN) 
δ 6.35 (t, J = 54.8 Hz) 
IR (thin 
film): 
3249 (br w), 2980 (w), 2954 (w), 1652 (br w), 1252 (w), 1199 (w), 1175 (w), 
1006 (m), 951 (m), 915 (m), 901 (m), 826(m), 787 (m), 755 (s), 711 (m),  
649 (m), 469 (m) 
MS: (ESI-LRMS) 
221.4 (M−K−H+Na)− 
TLC: 22:3 hexane/EtOAc (UV/CAM): Rf = 0.27 
Analysis: C8H10BF2KOSi (238.16) 
Calc.: C, 40.35 %; H, 4.23 %; K, 16.42 %; F, 15.95 % 
Found: C, 40.22 %; H, 4.19 %; K, 16.12 %; F, 14.1 % 
 
Optimized Preparation of (2-Biphenyl)dimethylsilanol 23a 
 
To a flame-dried, 50-mL, round-bottomed flask fitted with a condenser, in a glovebox was 
added 24 (297 mg, 1.25 mmol) and (PPh3)4Pd (72 mg, 63 μmol, 5 mol %). The apparatus was 
sealed under Ar, then removed from the glovebox. Bromobenzene (145 μL, 215 mg, 1.37 mmol, 
1.10 equiv) was then added, followed by DME (degassed, 11 mL). A solution of potassium 
carbonate (517 mg, 3.74 mmol, 3 equiv) in H2O (degassed, 1.3 mL, 2.85 M in K2CO3) was then 
added via syringe. The reaction was stirred at 80 °C under Ar for 18 h. The mixture was cooled to 
rt, then brine was added and the organic phase was extracted with EtOAc (3 × 20 mL), dried 
(Na2SO4) and concentrated in vacuo to 236 mg of a crude yellow-brown oil. This material was 
purified via column chromatography using 9:1 hexane/EtOAc as eluent to yield the title compound 
as a pale, yellow oil as the fourth fraction (210 mg, 920 μmol, 74%).  
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For the purposes of accelerated screening, 23a can also be synthesized from literature 
compound (2-biphenyl)dimethylsilane similarly to the [Ir(cod)Cl]2-catalysed oxidation of silane 
29 above.  
Data for 23a: 
TLC: 17:3 hexane/EtOAc (UV/I2): Rf = 0.48 
1H NMR: (500 MHz, CDCl3) 
δ 7.69 (d, 1 H, J = 7.4 Hz, HC(5)), 7.32–7.46 (m, 7 H, HC(3), HC(4), HC(9), 
HC(10), HC(11)), 7.22–7.29 (m, 1 H, HC(2)), 1.38 (s, 1 H, OH), 0.12 (s, 6 H, 
H3C(7)) 
13C NMR: (126 MHz, CDCl3) 
δ 148.41 (C(6)), 144.14 (C(8)), 137.77 (C(1)), 134.16 (C(2)), 129.43 (C(4)), 
129.18 (C(10)), 129.18 (C(3)), 129.15 (C(9)), 128.07 (C(11)), 127.42 (C(5)),  
1.54 (C(7)) 
 
Preparation of Potassium (2-Biphenyl)dimethylsilanolate 22a 
 
A suspension of KH (275 mg, 6.85 mmol, 1 equiv) in Et2O (anhydrous, 10 mL) in a flame-
dried, 50-mL Schlenk flask under Ar was cooled to 0 °C.  A solution of silanol 23a (1.564 g,  
6.85 mmol) in Et2O (anhydrous, 5 mL) under Ar was then added to the reaction mixture, dropwise.  
Vigorous H2 evolution was observed. The mixture was stirred at rt for 1 h, then passed through a 
cannula filter to any residual KH.  The filtrate was concentrated on high vacuum to give 1.67 g 
(91%) of the title compound as a foamy, white solid. This was stored in a Schlenk flask under Ar 
in a glovebox.  
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Data for 22a: 
1H NMR: (500 MHz, C6D6) 
δ 7.82 (dd, J = 7.4 Hz, 1.3 Hz, 1 H, HC(4)), 7.39 (d, J = 7.0 Hz, 2 H, HC(3), 
HC(6)), 7.35 (td, J = 7.2 Hz, 1.6 Hz, 1 H, C(5)), 7.24 (m, 2H, HC(8)), 7.10 (t, 
J = 7.7 Hz, 2 H, HC(9)), 7.00 (t, J = 7.4 Hz, 1 H, HC(10)), 0.14 (s, 6 H, H3C(7)) 
13C NMR: (101 MHz, C6D6) 
δ 148.2 (C(2)), 146.9 (C(7)), 146.4 (C(6)), 135.1 (C(1)), 130.6 (C(4)), 130.0 
(C9)), 129.9 (C(5)), 128.0 (C(8)), 126.7 (C(10)), 126.6 (C(3)), 6.6 (C(7)) 
 
Preparation of 4-Methoxy-1,1’:2’,1”-Terphenyl 21b 
 
Teraryl 21b was synthesized independently as a GC standard.  
4-Anisoylboronic acid (55 mg, 360 μmol, 1.2 equiv) and Cs2CO3 (195 mg, 600 μmol,  
2 equiv) were added to a 10-mL condenser flask equipped with a septum. (PPh3)4Pd (17 mg,  
15 μmol, 5 mol %) was added in a glovebox, then the flask sealed under an Ar atmosphere and 
removed from the glovebox. 2-Bromobiphenyl (52 μL, 70 mg, 300 μmol) was added, followed by 
4:1 1,4-dioxane/H2O (1.6 mL, 0.18 M in 2-bromobiphenyl). The orange-yellow biphasic mixture 
was stirred at reflux under positive Ar pressure for 12 h without color change. The mixture was 
cooled to rt, then H2O (3 mL) added and the organic phase was extracted with EtOAc (3 × 10 mL), 
washed with H2O (20 mL), dried (Na2SO4) and concentrated in vacuo to 83 mg of a crude brown 
oil. This material was purified via column chromatography with 99:1 hexane/Et2O as eluent to 
yield the title compound as white crystals (63 mg, 217 μmol, 72%). Spectral data matched 
literature values.188  
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EXPERIMENTAL PROCEDURES: CHAPTER 3 
Preparation of (S)-2-(N-Boc-amino)-1-(4-methoxyphenyl)-3-methylbutan-1-one 44c 
 
 To a solution of 4-bromoanisole (4.5 mL, 6.57 g, 3.51 mmol, 3.05 equiv) in THF 
(anhydrous, 135 mL, 0.26 M) at −78 °C in a 250-mL, two-necked, round-bottomed flask was added 
n-BuLi (1.6 M in hexanes, 21.6 mL, 34.6 mmol, 3 equiv) over 11 min. The solution became cloudy 
white over the course of the addition. The mixture was stirred at −78 °C for 40 min. A solution of 
45c (3.000 g, 11.5 mmol) in THF (anhydrous, 11.5 mL, 1.0 M) was then added at −78 °C over  
11 min. The now clear, pale yellow reaction mixture was stirred at −78 °C for a further 1 h. 
Saturated aqueous NH4Cl solution (46 mL) was then added slowly to quench, maintaining the 
temperature below −40 °C. The mixture was then warmed slowly to rt. The layers were separated, 
and the organic components extracted with further Et2O (3 × 80 mL). The combined organic layers 
were washed with brine (50 mL), dried (MgSO4), and concentrated in vacuo to 5.386 g crude, 
yellow oil. On standing for several hours, large, white crystals form. These were crushed and 
washed with hexane (3 × 15 mL), and then recrystallized from hot hexane to yield a total of  
2.399 g (7.80 mmol, 68% yield) white crystals, from two crops.  
Data for 44c: 
1H NMR: (400 MHz, CDCl3) 
δ 7.96 (d, J = 8.9 Hz, 2 H, HC(6)), 6.95 (d, J = 8.9 Hz, 2 H, HC(7)), 5.44 (d,  
J = 9.0 Hz, 1 H, NH), 5.17 (dd, J = 9.1, 4.2 Hz, 1 H, HC(1)), 3.88 (s, 3 H, H3C(9)), 
1.95-2.21 (m, 1 H, HC(3)), 1.44 (s, 9 H, H3C(12)), 1.02 (d, J = 6.8 Hz, 3 H, 
H3,AC(4)), 0.75 (d, J = 6.8 Hz, 3 H, H3,BC(4)) 
13C NMR: (101 MHz, CDCl3) 
δ 197.99 (C(2)), 163.91 (C(10), 156.01 (C(8)), 130.96 (C(5)), 128.20 (C(6)), 
113.98 (C(7)), 79.50 (C(1)), 59.13 (C(11)), 55.56 (C(9)), 31.99 (C(3)),  
28.36 (C(12)), 20.07 (CA(4)), 16.52 (CB(4)) 
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IR 
(powder): 
3319 (w), 2973 (w), 1695 (s), 1677 (s), 1601 (m), 1575 (m), 1514 (w), 1423 (w), 
1442 (m), 1384 (m), 1252 (m), 1232 (w), 1168 (s), 1084 (w), 1013 (w), 830 (w), 
794 (w), 608 (w), 540 (w) 
MS: (ESI-LRMS) 
330.2 (M+Na)+, 308.4 (M+H)+, 252.3 (M−t-Bu+2H)+, 208.3 (M−Boc+2H)+ 
 
Preparation of (1R,2S)-2-(N-Boc-amino)-1-(4-methoxyphenyl)-3-methyl-1-butanol 43c 
 
 To a solution of 44c (1.455 g, 4.73 mmol) in MeOH (anhydrous, 59 mL, 0.08 M) at  
−20 °C was added NaBH4 (358 mg, 9.47 mmol, 2 equiv), portionwise. The white suspension was 
stirred at −20 °C for 90 min. H2O (12 mL) was added at −20 °C, and the mixture allowed to warm 
to rt. MeOH was removed in vacuo, then EtOAc (20 mL) was added, and the layers separated. The 
organic layer was washed with H2O (15 mL), then brine (15 mL), dried (Na2SO4), and concentrated 
in vacuo to white crystals. These were washed with hexane (3 × 20 mL), and dried in vacuo to 
1.108 g (3.58 mmol, 76% yield) of white crystals of the title compound as a single diastereomer.  
Data for 43c (appearing as a mixture of rotamers at 20 °C): 
1H NMR: (500 MHz, CDCl3) 
δ 7.27 (d, J = 8.7 Hz, 2 H, HC(6)), 6.88 (d, J = 8.7 Hz, 2 H, HC(7)), 4.81 (t,  
J = 4.5 Hz, 0.9 H, HaC(2)), 4.54 (m, 0.1 H, HbC(2)), 4.32 (d, J = 9.8 Hz, 0.9 H, 
NHa), 4.03 (m, 0.1 H, NHb), 3.80 (s, 3.6 H, H3C(9)), 3.75 (dt, J = 10.9, 5.9 Hz,  
1 H, HaC(1)), 3.65 (m, 0.1 H, HbC(1)), 2.94 (d, J = 4.2 Hz, 0.9 H, OHa), 2.82 (d,  
J = 3.9 Hz, 0.1 H, OHb), 1.69 (oct, J = 6.6 Hz, 0.9 H, HaC(3)), 1.39 (s, 9.0 H, 
H3C(12), HbC(3)), 1.04 (d, J = 6.7 Hz, 3 H, H3,A,aC(4)), 0.98 (d, J = 6.7 Hz, 0.6 H, 
H3,A,bC(4)), 0.88 (d, J = 6.7 Hz, 3.6 H, H3,BC(4)) 
13C NMR: (125 MHz, CDCl3) 
δ 159.12 (C(10)), 156.95 (C(8)), 133.09 (C(5)), 127.99 (C(6)), 113.58 (C(7)),  
79.53 (C(2)), 74.92 (C(11)), 61.10 (C(1)), 55.29 (C(9)), 28.34 (C(3)),  
28.24 (C(12)), 20.90 (CA(4)), 17.99 (CB(4)) 
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IR 
(powder): 
3380 (w), 2978 (w), 2962 (w), 1836 (w), 1684 (m), 1614 (w), 1514 (s), 1351 (w), 
1305 (w), 1244 (m), 1169 (m), 1032 (m), 981 (m), 812 (w), 636 (w), 582 (w),  
554 (w) 
MS: (ESI-LRMS) 
332.5 (M+Na)+ 
 
Preparation of trans-(4S,5S)-4-isopropyl-5-(4-methoxyphenyl)oxazolidin-2-one trans-50c 
 
 To a solution of (1R,2S)-43c (106 mg, 340 µmol) in CH2Cl2 (anhydrous, 1.1 mL, 0.3 M) 
at 0 °C was added Et3N (57 µL, 42 mg, 410 µmol, 1.2 equiv), then MsCl (40 µL, 59 mg, 520 µmol, 
1.5 equiv), dropwise, over 5 min. The mixture was stirred at 0 °C for 5 min, then heated to reflux 
for 3 h. Saturated, aqueous NaHCO3 solution (1 mL) was added, and the layers separated. The 
organic layer was washed with further NaHCO3 solution (2 mL), brine (2 × 2 mL), then dried 
(Na2SO4), and concentrated to a cloudy yellow oil. This was filtered through a pipette plug of 
Celite, washing with EtOAc, to yield a yellow oil which very slowly crystallizes under high 
vacuum to ivory crystals of the title compound (72 mg, 89% yield, 96:4 dr).  
Data for trans-50c: 
1H NMR: (500 MHz, CDCl3) 
δ 7.29 (d, J = 8.8 Hz, 2 H, HC(6)), 6.91 (d, J = 8.7 Hz, 2 H, HC(7)), 6.60 (br s,  
1 H, NH), 5.16 (d, J = 5.5 Hz, 1 H, HC(2)), 3.81 (s, 3 H, H3C(9)), 3.55 (t,  
J = 5.7 Hz, 1 H, HC(1)), 1.85 (oct, J = 6.7 Hz, 1 H, HC(3)), 1.00 (dd, J = 6.7,  
1.2 Hz, 3 H, H3,AC(4)), 0.93 (dd, J = 6.7, 1.2 Hz, 3 H, HBC(4)) 
13C NMR: (101 MHz, CDCl3) 
δ 159.83 (C(8), C(10)), 131.26 (C(5)), 127.58 (C(6)), 114.11 (C(7)), 81.43 (C(2)), 
66.04 (C(1)), 55.23 (C(9)), 32.43 (C(3)), 18.18 (CA(4)), 17.64 (CB(4)) 
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IR 
(crystals): 
3326 (br w), 2960 (w), 2917 (w), 1751 (m), 1731 (s), 1614 (w), 1517 (w),  
1370 (w), 1256 (m), 1227 (w), 1175 (m), 1081 (w), 1032 (m), 988 (s), 836 (m), 
818 (m), 770 (w), 723 (w), 631 (m), 584 (w), 563 (w), 529 (w) 
MS: (ESI-LRMS) 
471.4 (2M+H)+, 258.4 (M+Na)+, 236.3 (M+H)+, 192.3 (M−CO2+H)+ 
Preparation of cis-(4S,5R)-4-isopropyl-5-(4-methoxyphenyl)oxazolidin-2-one cis-50c 
 
 To a suspension of NaH (16 mg, 0.65 mmol, 2 equiv) in DMF (anhydrous, 0.3 mL,  
0.11 M) was added a solution of (1R,2S)-43c (100 mg, 0.32 mmol) in DMF (anhydrous, 2.0 mL, 
0.16 M). The white suspension was stirred at rt for 4 h, becoming a clear, pale yellow solution. 
Saturated, aqueous NH4Cl solution was added slowly to quench, promoting effervescence. The 
organic components were extracted with Et2O (3 × 4 mL), washed with 20% aqueous LiCl solution 
(2 × 3 mL), dried (Na2SO4) and concentrated in vacuo to a very pale yellow oil. This was filtered 
through a pipette plug of SiO2, washing with CH2Cl2, which after solvent evaporation, yielded the 
title compound as white crystals (76 mg, quantitative yield, 98:2 dr).  
Data for cis-50c: 
1H NMR: (400 MHz, CDCl3) 
δ 7.28 (d, J = 8.7 Hz, 2 H, HC(6)), 6.90 (d, J = 8.7 Hz, 2 H, HC(7)), 6.31 (s, 1 H, 
NH), 5.60 (d, J = 8.0 Hz, 1 H, HC(2)), 3.82 (s, 3 H, H3C(9)), 3.79 (d, J = 7.9 Hz,  
1 H, HC(1)), 1.51 (oct, J = 6.6 Hz, 1 H, HC(3)), 0.85 (d, J = 6.6 Hz, 3 H, H3,AC(4)), 
0.66 (d, J = 6.6 Hz, 3 H, H3,BC(4)) 
13C NMR: (101 MHz, CDCl3) 
δ 162.46 (C(10)), 160.55 (C(8)), 128.1 (C(5)), 127.17 (C(6)), 113.55 (C(7)),  
81.15 (C(2)), 63.17 (C(1)), 55.11 (C(9)), 31.27 (C(3)), 19.26 (CA(4)), 18.40 (CB(4)) 
IR (thin 
film): 
3256 (br w), 2961 (w), 2926 (w), 1745 (s), 1612 (w), 1515 (m), 1365 (w),  
1301 (w), 1250 (m), 1176 (m), 1033 (m), 1017 (w), 1001 (m), 837 (w) 
MS: (ESI-LRMS) 
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471.4 (2M+H)+, 236.3 (M+H)+, 192.3 (M−CO2+H)+ 
 
Preparation of (1R,2S)-2-amino-1-(4-methoxyphenyl)-3-methyl-1-butanol 34c 
 
 A 10-mL, round-bottomed flask was charged with trans-50c (48 mg, 205 µmol), then  
1 N NaOH solution (1.9 mL, 0.2 M in oxazolidinone). The oxazolidinone did not dissolve. The 
mixture was heated to reflux for 6 h. After cooling to rt, the organic components were extracted 
with EtOAc (4 × 4 mL), dried (Na2SO4), and concentrated in vacuo to a pale, yellow oil, which 
crystallized overnight to white crystals. Recrystallization from hexane gave the title compound as 
white crystals (43 mg, 200 µmol, quantitative yield).  
Data for (1R,2S)-34c: 
1H NMR: (500 MHz, CDCl3) 
δ 7.27 (d, J = 8.9 Hz, 2 H, HC(6)), 6.87 (d, J = 8.7 Hz, 2 H, HC(7)), 4.56 (d,  
J = 6.3 Hz, 1 H, HC(2)), 3.80 (s, 3 H, H3C(9)), 2.72 (t, J = 6.1 Hz, 1 H, HC(1)), 
1.69 (oct, J = 6.5 Hz, 1 H, HC(3)), 1.01 (d, J = 6.8 Hz, 3 H, H3,AC(4)), 0.89 (d,  
J = 6.8 Hz, 3 H, H3,BC(4)) 
13C NMR: δ 159.10 (C(8)), 133.98 (C(5)), 128.12 (C(6)), 113.69 (C(7)), 74.50 (C(2)),  
61.82 (C(1)), 55.26 (C(9)), 29.1 (C(3)), 20.64 (CA(4)), 17.11 (CB(4)) 
MS: (ESI-LRMS) 
192.4 (M−H2O)+ 
IR (thin 
film): 
3361 (br, w), 2956 (w), 2928 (w), 1611 (w), 1511 (m), 1464 (w), 1367 (w),  
1303 (w), 1245 (m), 1173 (w), 1034 (m), 833 (m), 574 (w) 
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Preparation of N,N’-bis((S,S)-1-hydroxy-1-(4-methoxyphenyl)-3-methylbutan-2-
yl)cyclopentane-1,1-dicarboxamide 49c 
 
 To a solution of 34c (215 mg, 1.03 mmol, 2 equiv) in CH2Cl2 (anhydrous, 1.4 mL, 0.75 M) 
was added Et3N (360 μL, 259 mg, 2.6 mmol, 5 equiv) in one portion. A solution of 52a (100 mg, 
0.51 mmol) in CH2Cl2 (anhydrous, 2.6 mL, 0.2 M) was then added dropwise at 0 °C over 5 min. 
The mixture was brought to rt and stirred for 12 h. H2O (3 mL) was added to quench. CH2Cl2  
(3 mL) was added, and the layers separated. The organic components were extracted with further 
CH2Cl2 (2 × 6 mL), dried (Na2SO4), and concentrated in vacuo to a white solid. This was 
recrystallized from hexane/CH2Cl2 to white crystals of the title compound (204 mg, 380 μmol, 
74%).  
Data for 49c: 
1H NMR: (500 MHz, CDCl3) 
δ 7.25 (d, J = 8.5 Hz, 4 H, HC(6)), 6.87 (d, J = 8.7 Hz, 4 H, HC(7)), 6.22 (d,  
J = 9.5 Hz, 2 H, NH), 4.43 (dd, J = 6.5, 4.3 Hz, 2 H, HC(2)), 4.02 (ddd, J = 9.5, 
7.0, 5.0 Hz, 2 H, HC(1)), 3.79 (s, 6 H, H3C(9)), 3.31 (d, J = 4.9 Hz, 2 H, HAC(12)), 
2.39 (m, 2 H, HBC(12)), 1.93 (m, 2 H, HAC(13)), 1.61 (m, 6 H, HC(3), HBC(13), 
OH), 0.88 (d, J = 6.8 Hz, 6 H, H3,AC(4)), 0.80 (d, J = 6.9 Hz, 3 H, H3,BC(4)). 
13C NMR: (125 MHz, CDCl3) 
δ 174.15 (C(10)), 159.19 (C(8)), 133.96 (C(5)), 127.56 (C(6)), 113.94 (C(7)),  
74.50 (C(2)), 62.41 (C(1)), 59.95 (C(11)), 55.26 (C(9)), 34.78 (C(12)),  
29.71 (C(3)), 28.69 (C(13)), 24.79 (C(13)), 20.49 (CA(4)), 16.94 (CB(4)) 
IR (thin 
film): 
3455 (br w), 3405 (br w), 2957 (w), 2922 (br w), 2872 (w), 2851 (w), 1740 (w), 
1655 (m), 1628 (w), 1613 (w), 1510 (s), 1462 (w), 1302 (w), 1241 (s), 1172 (w), 
1041 (m), 822 (m), 584 (w), 538 (w) 
MS: (ESI-LRMS) 
541.5 (M+H)+, 523.5 (M−H2O)+, 505.5 (M−2H2O)+ 
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Preparation of (S,S,S,S)-2,2’-(cyclopentane-1,1-diyl)bis(4-isopropyl-5-(4-methoxyphenyl)-
4,5-dihydrooxazole) 41c 
 
 A 10-mL, round-bottomed flask was charged with 49c (95 mg, 180 μmol) and xylenes  
(2.7 mL, 0.07 M), then Bu2SnCl2 (11 mg, 35 μmol, 20 mol %) was added. The mixture was brought 
to reflux and stirred for 20 h. The solvent was then removed in vacuo to yield a crude mixture of 
white crystals and yellow oil. This was separated via column chromatography using  
1:9 Et2O/PhMe as eluent, to give the title compound as white crystals (60 mg, 120 μmol, 67%).  
Data for (S,S,S,S)-41c: 
1H NMR: (500 MHz, CDCl3) 
δ 7.13 (d, J = 8.7 Hz, 4 H, HC(6)), 6.68 (d, J = 8.7 Hz, 4 H, HC(7)), 5.04 (d,  
J = 6.6 Hz, 2 H, HC(1)), 3.85 (dd, J = 6.7, 5.3 Hz, 2 H, HC(2)), 3.75 (s, 6 H, 
H3C(9)), 2.47–2.61 (m, 2 H, HAC(12)), 2.14–2.24 (m, 2 H, HBC(12)), 1.83 (m,  
6 H, HC(3), H2C(13)), 0.94 (d, J = 6.8 Hz, 6 H, H3,AC(4)), 0.91 (d, J = 6.8 Hz,  
6 H, H3,BC(4)) 
13C NMR: (126 MHz, CDCl3) 
δ 167.44 (C(10)), 159.29 (C(8)), 133.81 (C(5)), 127.82 (C(6)), 113.81 (C(7)),  
83.82 (C(2)), 80.32 (C(1)), 55.12 (C(9)), 49.39 (C(11), 36.05 (C(12)), 32.61 (C(3)), 
25.11 (C(13)), 18.37 (CA(4)), 17.96 (CB(4)) 
IR (thin 
film): 
2954 (w), 2875 (w), 2937 (w), 1655 (m), 1614 (w), 1516 (m), 1460 (w), 1306 (w), 
1247 (s), 1178 (m), 1155 (w), 1032 (w), 926 (w), 821 (s), 781 (w), 546 (m) 
MS: (ESI-LRMS) 
505.6 (M+H)+ 
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Preparation of 1-(5-benzodioxolyl)-2,2,2-trichloroethanone 54d 
 
 To a solution of 53d (100 mg, 370 μmol) in CH2Cl2 (anhydrous, 3.8 mL, 0.1 M) in a  
10-mL recovery flask fitted with a reflux condenser was added PCC (240 mg, 1.11 mmol, 3 equiv), 
followed by 3 Å MS (100 mg), and silica gel (240 mg). The red solution was heated to reflux, at 
which point it turned brown. The reaction mixture was stirred under reflux for 24 h. After cooling 
to rt, Et2O (4 mL) was added, and the mixture was filtered through Celite to remove the brown 
precipitate, washing with CH2Cl2 (3 × 10 mL). The filtrate was washed with 0.6 N HCl (2 ×  
10 mL), then saturated NaHCO3 solution (2 × 10 mL), dried (Na2SO4), and concentrated in vacuo 
to 95 mg crude brown oil. This was purified by Kugelrohr distillation at 800 mTorr to yield 92 mg 
(345 μmol, 93% yield) of a colorless oil.  
Data for 54d: 
bp: 92 °C (ABT), 800 mTorr 
1H NMR: (500 MHz, CDCl3) 
δ 7.95 (d, J = 8.1 Hz, HC(8)), 7.69 (s, 1 H, HC(4)), 6.89 (d, J = 8.2 Hz, 1 H, HC(7)), 
6.90 (s, 2 H, H2C(6)) 
13C NMR: (126 MHz, CDCl3) 
δ 179.50 (C(1)), 152.81 (C(6)), 147.72 (C(5)), 128.75 (C(3)), 122.67(C(8)), 111.18 
(C(4)), 107.96 (C(7)), 102.26 (C(9)), 95.62 (C(2)). 
IR (neat): 2907 (w), 1697 (m), 1613 (m), 1503 (m), 1486 (m), 1442 (m), 1350 (m), 1248 (s), 
1104 (m), 1036 (s), 932 (m), 872 (m), 842 (m), 828 (s), 761 (s), 727 (m), 673 (s), 
636 (m), 566 (w) 
MS: (ESI-LRMS) 
288.9 [M+Na]+ 
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Preparation of (R)-1-(5-benzodioxolyl)-2,2,2,-trichloroethanol (R)-53d 
 
 To a solution of 54d (5.002 g, 18.7 mmol) in PhMe (anhydrous and degassed, 187 mL,  
0.1 M) in a three-necked, 500-mL, round-bottomed flask equipped with an Ar line and two septa 
under Ar was added (R)-2-methyl-4,4-diphenyltetrahydro-1H,3H-pyrrolo[3,4-
c][1,3,2]oxazaborole ((R)-2-Me-Corey-Itsuno oxazaborolidine) (1 M in PhMe, 1.87 mL,  
1.87 mmol, 10 mol %). The colorless to pale yellow mixture was cooled to −78 °C. A solution of 
catecholborane (4.00 mL, 4.485 g, 37.4 mmol, 2 equiv) in THF (anhydrous and degassed,  
37.5 mL, 1 M) was added dropwise over 13 min. The pale yellow solution was stirred at −78 °C 
for 8 h, then brought to rt and stirred for a further 16 h. H2O (100 mL) was added, giving 
effervescence, and leading the yellow color to mostly disappear after about 30 s. The layers were 
separated, and the organic components extracted with further EtOAc (2 × 100 mL), and the organic 
layers washed with 1 M NaOH (3 × 50 mL), then 1 M HCl (3 × 50 mL), and dried (MgSO4) and 
concentrated in vacuo to 5.206 g crude, green oil. This was separated via column chromatography 
using 4:1 hexane:ethyl acetate as eluent, to provide 4.501 g (16.7 mmol, 89% yield) of a pale 
yellow oil as the second fraction, found to have 96.5:3.5 er. This had identical spectral data to the 
racemic compound known in the literature.158 Absolute configuration of the stereocenter was 
assigned by analogy.  
Additional data for (R)-53d: 
HPLC: tR 16.4 min (96.5%); tR 20.3 min (3.5%) (OJ-H, hexane/isopropanol = 90:10,  
1.0 mL min-1, 220 nm, 20 °C) 
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Screening Conditions for the Attempted Preparation of 1-azido-1-(5-benzodioxolyl)acetic 
acid 55d 
 
Conditions were modified from the method of Aitken.157 A solution of base (1 equiv), 
additive, and NaN3 (2 equiv) in H2O (0.8 mL, 0.9 M in NaN3) was added to a vigorously-stirred 
solution of 38r (100 mg, 0.4 mmol) in DME (2.2 mL, 0.17 M) in a 7-mL vial at 10 °C, dropwise. 
The mixture was stirred at 10 °C for 5 min, then warmed to the reaction temperature, and stirred 
for 24 h. Et2O (1 mL) was added, and the layers separated. The organic layer was washed with 
1.25 N NaOH solution (1 mL), and the aqueous phase cooled to 0 °C. This first organic layer was 
dried (MgSO4), and concentrated in vacuo to yield recovered starting material. 1 M KH2PO4 
solution, or solid KH2PO4, was then added to the aqueous phase until pH 4 was attained. The 
cloudy solution was extracted with EtOAc (3 × 1 mL), giving a clear biphase. The organic layers 
were dried (MgSO4), and concentrated in vacuo to yield the crude product mixture.  
Preparation of 1-(2-methoxyphenyl)-2,2,2-trichloroethanol (R)-53e 
 
 (R)-53e was produced via a modified literature procedure, using (R)-2-methyl Corey-
Itsuno oxazolidinone rather than the 2-butyl variant. Spectral data matched the literature.157  
Additional Data for (R)-53e: 
HPLC: tR 10.9 min (99.3%); tR 13.0 min (0.7%) (OJ-H, hexane/isopropanol = 85:15,  
1.0 mL min-1, 220 nm, 20 °C) 
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Improved preparation of 1-(2-methoxyphenyl)-2,2,2-trichloroethanone 54e by PCC 
oxidation 
 
 To a solution of 53e (17.794 g, 70.4 mmol) in CH2Cl2 (anhydrous, 700 mL, 0.1 M) in a  
2-L, round-bottomed flask fitted with a reflux condenser was added PCC (45.515 g, 211 mmol,  
3 equiv), followed by 3 Å MS (2 g), and silica gel (46 g). The red solution was heated to reflux, at 
which point it turned brown. The reaction mixture was stirred under reflux for 24 h. After cooling 
to rt, i-PrOH (18 mL) was added to quench, followed by Et2O (300 mL), and the mixture was 
filtered through Celite to remove the brown precipitate, washing with CH2Cl2 (2 × 100 mL). The 
filtrate was concentrated in vacuo to half its original volume to facilitate workup. The concentrated 
filtrate was washed with 0.6 N HCl (2 × 200 mL), then saturated NaHCO3 solution (2 × 200 mL), 
and brine (200 mL). Lastly, it was dried (Na2SO4), and concentrated in vacuo to 17.418 g crude, 
green oil. Chromium byproducts were removed by Kugelrohr distillation at 300 mTorr, to yield 
16.639 g yellow oil. This was purified via column chromatography in two portions using  
9:1 hexane:ethyl acetate as eluent, to yield 15.407 g (345 μmol, 93% yield) of a colorless oil. 
Spectral data matched the literature.157  
Additional Data for 54e: 
bp: 115 °C (ABT), 300 mTorr 
 
Screening Conditions for the Attempted Preparation of 1-azido-1-(2-methoxyphenyl)acetic 
acid 55e 
 
Conditions were modified from the method of Aitken.157 A solution of base (1 equiv) and 
NaN3 (2 equiv) in H2O (1.3 mL, 0.33 M in base) was added to a vigorously-stirred solution of 53e 
(100 mg, 0.4 mmol) in DME (1.0 mL, 0.40 M) at 10 °C. The mixture was stirred at 10 °C for  
5 min, then warmed to rt and stirred for 24 h. Et2O (1 mL) was added, and the layers separated. 
The organic layer was washed with 1.25 N NaOH solution (1 mL), and the aqueous phase cooled 
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to 0 °C. This first organic layer was dried (MgSO4), and concentrated in vacuo to yield recovered 
starting material. 1 M KH2PO4 solution, or solid KH2PO4, was then added to the aqueous phase 
until pH 4 was attained. The cloudy solution was extracted with EtOAc (3 × 1 mL), giving a clear 
biphase. The organic layers were dried (MgSO4), and concentrated in vacuo to yield a crude 
mixture.  
Preparation of (R)-N-Boc-2-(4-tetrahydropyranyl)glycine 42f 
 
 The crude mixture containing 47f·HCl (800 mg) from the Strecker hydrolysis according 
to Jacobsen was dissolved in 2:1 H2O/1,4-dioxane (18 mL).  1 N NaOH (12 mL) was added, 
checking the pH regularly so as not to let the mixture become >pH 8. The brown solution turns 
yellow. The reaction mixture is cooled to 0 °C, then Boc2O and NaHCO3 were added, and the 
solution turns cloudy yellow. The mixture was brought to rt and stirred for 24 h, becoming light 
yellow. The reaction mixture was diluted with H2O (10 mL), and transferred to a separatory funnel, 
where it was extracted with EtOAc (4 × 15 mL). The aqueous layer was acidified to pH 4 with  
1 M KHSO4, at which point a substance oils out. This was extracted with CH2Cl2 (4 × 15 mL), 
dried (Na2SO4) and concentrated in vacuo to a white solid foam. This was dissolved in EtOAc and 
filtered. The white crystals of the filtrand were collected by dissolution in MeOH, as the title 
compound (385 mg). This crude compound was brought onto the next reaction without further 
purification. Spectral data matched published values.189  
Preparation of (R)-N-methoxy-N-methyl-2-(methylamino)-2-(4-
tetrahydropyranyl)acetamide 45f 
 
 A solution of crude 42f (200 mg, 0.77 mmol) in CH2Cl2 (8 mL, 0.1 M) was cooled to 0 °C, 
then CDI (166 mg, 1.03 mmol, 1.33 equiv) was added. The mixture was stirred at 0 °C for 30 min. 
Then, Et3N (145 μL, 104 mg, 1.03 mmol, 1.33 equiv) was added, followed by  
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N,O-dimethylhydroxylamine hydrochloride (100 mg, 1.03 mmol, 1.33 equiv). The clear, pale 
yellow solution was allowed to warm slowly to rt in the ice bath, and stirred for 38 h. 1 N HCl  
(10 mL) was added, and the layers separated. The organic layer was washed with 1 N HCl  
(10 mL), saturated aqueous NaHCO3 solution (2 × 10 mL), then brine, and dried (MgSO4) and 
concentrated in vacuo to the title compound as a yellow solid (180 mg, 77%).  
Data for 45f: 
1H NMR: 1H NMR (500 MHz, CDCl3) 
δ 5.16 (d, J = 9.7 Hz, 1 H, HC(1)), 4.65 (br m, 1 H, NH), 3.97 (ddd, J = 15.8, 11.8, 
4.9 Hz, 2 H, H2,AC(5)), 3.78 (s, 3 H, H3C(7)), 3.34 (dddd, J = 13.8, 11.8, 3.9, 2.0 
Hz, 2 H, H2,B(C(5)), 3.22 (s, 3 H, H3C(6)), 2.07–1.73 (m, 1 H, HC(3)), 1.50–1.62 
(m, 2 H, H2,AC(4)), 1.39–1.50 (m, 11 H, H2,BC(4), H3C(10)) 
13C NMR: 13C NMR (126 MHz, CDCl3) 
δ 155.66 (C(2)), 79.66 (C(9)), 67.76 (CA(5)), 67.61 (CB(5)), 61.70 (C(7)), 53.81 
(C(1)), 38.61 (C(3)), 31.82 (C(6)), 29.34 (C(4)), 28.35 (CA(10)), 28.19 (CB(10)) 
IR (thin 
film): 
2940 (w, br), 2845 (w), 1709 (s), 1655 (s), 1520 (w), 1390 (w), 1366 (w), 1247 (w), 
1168 (s), 1093 (w), 1018 (w), 986 (w), 856 (w) 
MS: (ESI-LRMS) 
303.4 [M+H]+ 
 
Preparation of (R)-2-(Boc-amino)-1-phenyl-2-(4-tetrahydropyranyl)ethan-1-one 44f 
 
 To a solution of 45f (256 mg, 0.85 mmol) in THF (anhydrous and degassed, 8 mL,  
0.11 M) at −78 °C was added PhLi (1.74 M in Bu2O, 1.5 mL, 2.5 mmol, 3 equiv) over 14 min. The 
light brown reaction mixture was stirred at −78 °C for a further 7 h. Saturated aqueous NH4Cl 
solution (46 mL) was then added slowly to quench, maintaining the temperature below −40 °C. 
The mixture was then warmed slowly to rt. The layers were separated, and the organic components 
extracted with further Et2O (3 × 80 mL). The combined organic layers were washed with brine  
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(50 mL), dried (MgSO4), and concentrated in vacuo to a crude, yellow oil. This was separated via 
column chromatography using 1:4 EtOAc/hexanes as eluent, to yield the title compound as a white 
solid (190 mg, 70%).  
Data for 44f: 
1H NMR: (500 MHz, CDCl3) 
δ 8.00 (d, J = 7.5 Hz, 2 H, HC(7)), 7.61 (t, J = 7.5 Hz, 1 H, HC(9)), 7.51 (t,  
J = 7.8 Hz, 2 H, HC(8)), 5.47 (d, J = 8.9 Hz, 1 H, NH), 5.27 (dd, J = 8.9, 4.6 Hz,  
1 H, HC(1)), 3.78–4.01 (m, 2 H, H2,AC(5), H2,BC(5)), 3.31 (td, J = 11.3, 3.7 Hz,  
1 H, H2,CC(5)), 3.23 (td, J = 11.9, 2.3 Hz, 1 H, H2,DC(5)), 2.04 (m, 3 H, HC(3), 
H2,AC(4)), 1.52–1.67 (m, 2 H, H2,BC(4)), 1.45 (s, 9 H, H3C(12)) 
IR (thin 
film): 
2925 (w), 2852 (w), 1710 (m), 1682 (s), 1697 (w), 1500 (w), 1448 (w), 1366 (w), 
1240 (w), 1164 (m), 1090 (w), 1002 (w), 918 (w), 876 (w), 690 (w), 570 (w),  
517 (w) 
MS: (ESI-LRMS) 
342.4 (M+Na)+, 203.4 (M−NHBoc)+ 
Optical 
Rotation: 
[α]D
22 −3.42 (c = 0.567, MeOH) 
 
Preparation of (1S,2R)-2-(Boc-amino)-1-phenyl-2-(4-tetrahydropyranyl)ethan-1-ol 43f 
 
 To a solution of 44f (190 mg, 0.6 mmol) in MeOH (anhydrous, 7.5 mL, 0.08 M) at −20 °C 
was added NaBH4 (45 mg, 1.2 mmol, 2 equiv), portionwise over 7 min. The white suspension was 
stirred at −20 °C for 2 h. H2O (2.5 mL) was added at −20 °C, and the mixture allowed to warm to 
rt. MeOH was removed in vacuo, then EtOAc (5 mL) was added, and the layers separated. The 
organic layer was washed with H2O (5 mL), then brine (5 mL), dried (Na2SO4), and concentrated 
in vacuo to the title compound as a white solid (178 mg, 93%).  
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Data for 43f: 
1H NMR: (500 MHz, CDCl3) 
δ 7.28–7.40 (m, 5 H, HC(7), HC(8), HC(9)), 4.87 (t, J = 4.6 Hz, 1 H, HC(2)),  
4.46 (d, J = 9.9 Hz, 1 H, HC(1)), 3.87–4.06 (m, 3 H, HAC(5), HBC(5), HCC(5)), 
3.85 (m, 1 H, HDC(5)), 3.32 (m, 3 H, HC(3), H2,AC(4)), 3.12 (br s, 1 H, OH),  
1.53–1.69 (m, 2 H, H2,BC(4)), 1.39 (s, 9 H, H3C(12)) 
IR (thin 
film): 
3356 (br w), 2936 (w), 2848 (w), 1694 (s), 1496 (w), 1454 (w), 1391 (w),  
1366 (m), 1243 (w), 1169 (s), 1022 (m), 998 (w), 853 (w), 766 (w), 701 (m),  
528 (w) 
 
Preparation of (1S,2R)-2-amino-1-phenyl-2-(4-tetrahydropyranyl)ethan-1-ol 34f 
 
 To a solution of 34f (34 mg, 0.1 mmol) in MeOH (anhydrous, 1 mL, 0.1 M) was added 
TMSCl (68 μL, 57 mg, 0.53 mmol, 5 equiv) in one portion. The mixture was stirred at rt for 10 h. 
The reaction mixture was then extracted with EtOAc (3 × 5 mL). The aqueous layer was basified 
with 28% NH4OH to pH 12, and the mixture extracted with EtOAc (3 × 5 mL), dried (Na2SO4) 
and concentrated in vacuo to the title compound as a white solid (23 mg, 100%).  
Data for (1R,2S)-34f: 
1H NMR: (500 MHz, CDCl3) 
δ 7.26–7.40 (m, 5 H, HC(7), HC(8), HC(9)), 4.62 (d, J = 5.9 Hz, 1 H, HC(2)),  
3.86–4.03 (m, 2 H, H2,AC(5)), 3.31 (dtd, J = 18.4, 11.4, 2.1 Hz, 2 H, H2,BC(5)),  
2.79 (t, J = 5.3 Hz, 1 H, HC(1)), 1.51–1.69 (m, 4 H, H2C(4)), 1.43 (tdd, J = 12.3, 
9.0, 6.0 Hz, 1 H, HC(3)) 
HRMS: (ESI) 
Calcd. for C13H20NO2
+ (M+H)+: 222.1494, found: 222.1495 
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Preparation of N,N’-bis((1S,2R)-2-hydroxy-2-phenyl-1-(4-
tetrahydropyranyl)ethyl)cyclopentane-1,1-dicarboxamide 49f 
 
 To a solution of 34f (21 mg, 0.1 mmol, 2 equiv) in CH2Cl2 (anhydrous, 0.4 mL) was added 
Et3N (33 μL, 24 mg, 0.24 mmol, 5 equiv) in one portion. A solution of 52a (9.3 mg, 0.05 mmol) 
in CH2Cl2 (anhydrous, 0.24 mL, 0.2 M) was then added dropwise at 0 °C over 1 min. The white 
suspension was brought to rt and stirred for 16 h. H2O (3 mL) was added to quench. CH2Cl2  
(3 mL) was added, and the layers separated. The organic components were extracted with further 
CH2Cl2 (2 × 6 mL), dried (Na2SO4), and concentrated in vacuo to the title compound as a white 
solid (21 mg, 78%), as a mixture of diastereomers.   
Data for 49f: 
1H NMR: (500 MHz, CDCl3) 
δ 7.27–7.41 (m, 10 H, HC(7), HC(8), HC(9)), 6.16 (d, J = 9.5 Hz, 2 H, NH),  
4.85 (d, J = 5.6 Hz, 2 H, HC(2)), 4.19 (m, 2 H, HC(1)), 3.77–3.89 (m, 4 H, 
H2,AC(5)), 3.22–3.34 (m, 4 H, H2,BC(5)), 3.10 (d, J = 4.0 Hz, 2 H, OH), 2.09 (br t, 
J = 7.3 Hz, 2 H, HC(3)), 1.84–1.93 (br m, 2 H, H2,AC(12)), 1.28–1.72 (m, 16 H, 
H2C(4), H2,BC(12), H2C(13)) 
IR (thin 
film): 
3347 (br w), 2961 (w), 2926 (w), 2852 (w), 1673 (m), 1472 (w), 1368 (w),  
1269 (w), 1173 (m), 1098 (m), 1029 (m), 798 (m) 
MS: (ESI-LRMS) 
565.3 (M+H)+ 
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Conditions and Spectra for Morpholine Synthesis 
General Screening Procedure for Enantioselective SnAP Synthesis of  
3-(4-Methoxyphenyl)morpholine 37c 
 
Reactions were run according to the procedure of Bode, outlined below.173  
The bisoxazoline ligand (see Table 12 for masses used, 0.01 mmol, 20 mol %) and 
anhydrous Cu(OTf)2 (3.6 mg, 0.01 mmol, 20 mol %) were dissolved in HFIP/CH2Cl2  
(1:1, anhydrous, 0.4 mL) and stirred at rt for 6 h under Ar in a 1-dram vial. An immediate color 
change occurred, the color often intensifying over the course of stirring. A solution of freshly-
prepared imine 40c (24 mg, 0.05 mmol) in CH2Cl2 (anhydrous, 0.6 mL) was injected in one portion 
and the resulting mixture was stirred at rt for 20 h. The reaction mixture was diluted with a stock 
solution of 1,3,5-trimethoxybenzene (internal standard, 0.025 mmol, 0.5 M) in CH2Cl2 (anhydrous, 
0.5 mL), treated with a solution of 12% aq NH4OH and brine (1:1, 1 mL), and stirred vigorously 
for 15 min at rt. The layers were separated and the aqueous layer was extracted with CH2Cl2  
(2 × 2 mL). The combined organic layers were washed with H2O (2 mL) and brine (2 mL), dried 
(Na2SO4), and concentrated in vacuo. A sample for HPLC analysis was obtained by dissolving 
roughly half of this crude mixture in hexane (0.5 mL) in a 2-dram vial, washing with 3 N HCl  
(1 mL) and separating the layers. The aqueous layer was basified to pH 12 with 3 N NaOH  
(~1 mL), and extracted with hexane (2 × 0.5 mL) to yield the purified title compound. Spectral 
and chromatographic data matched the literature.127  
Additional Data for 37c: 
HPLC: tR 10.0 min (49.8%); tR 10.9 min (50.2%) (AD-H, hexane/isopropanol = 96:4 + 
0.1% DEA, 1.0 mL min-1, 220 nm, 24 °C) 
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Figure 6. HPLC Chromatogram of Racemic 37c 
Table 12. Bisoxazoline Screening Reactions and CSP-HPLC Chromatograms 
Run 1 
Ligand MW: 504.67 
5.0 mg ligand 
 
 
Enantiomeric Ratio of 37c 
a 32:68 
b 31:69 
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Run 2 
Ligand MW: 490.65 
4.9 mg ligand 
  
 
Enantiomeric Ratio of 37c 
a 29:71 
b 30:70 
 
Run 3 
Ligand MW: 390.53 
3.9 mg ligand 
  
 
Enantiomeric Ratio of 37c 
a 35:65 
b 35:65 
 
Run 4 
Ligand MW: 486.62 
4.9 mg ligand 
 
 
Enantiomeric Ratio of 37c 
a 24:76 
b 25:75 
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Run 5 
Ligand MW: 544.65 
5.4 mg ligand 
 
 
Enantiomeric Ratio of 37c 
a 23:77 
b 22:78 
 
Run 6 
Ligand MW: 378.60 
3.8 mg ligand 
 
 
Enantiomeric Ratio of 37c 
a 37:63 
b 36:64 
 
Run 7 
Ligand MW: 322.49 
3.2 mg ligand 
 
 
Enantiomeric Ratio of 37c 
a 27:73 
b 32:68 
c 26:74 
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Run 8 
Ligand MW: 490.64 
4.9 mg ligand 
 
 
Enantiomeric Ratio of 37c 
a 37:63 
b 36:64 
 
Run 9 
Ligand MW: 690.69 
6.9 mg ligand 
 
 
Enantiomeric Ratio of 37c 
a 59:41 
b 67:33 
c 68:32  
Run 10 
Ligand MW: 638.81 
6.4 mg ligand 
 
 
Enantiomeric Ratio of 37c 
a 13:87 
b 17:83 
c 18:82 
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Run 11 
Ligand MW: 770.62 
7.7 mg ligand 
 
 
Enantiomeric Ratio of 37c 
a 36:64 
b 35:65 
 
Run 12 
Ligand MW: 618.73 
6.2 mg ligand 
 
 
Enantiomeric Ratio of 37c 
a 28:72 
b 27:73 
 
Run 13 
Ligand MW: 1056.64 
10.6 mg ligand 
 
 
Enantiomeric Ratio of 37c 
a 49:51 
b 50:50 
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Run 14 
Ligand MW: 434.43 
4.3 mg ligand 
 
 
Enantiomeric Ratio of 37c 
a 43:57 
b 44:56 
 
Run 15 
Ligand MW: 750.69 
7.5 mg ligand 
 
 
Enantiomeric Ratio of 37c 
a 37:63 
b 36:64 
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Run 16 
Ligand MW: 934.98 
9.3 mg ligand 
 
 
Enantiomeric Ratio of 37c 
a 47:53 
b 48:52 
 
Run 17 
Ligand MW: 442.60 
4.4 mg ligand 
 
 
Enantiomeric Ratio of 37c 
a 63:37 
b 63:37 
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Run 18 
Ligand MW: 648.65 
6.5 mg ligand 
 
 
Enantiomeric Ratio of 37c 
a 47:53 
b 47:53 
 
Run 19 
Ligand MW: 444.62 
4.4 mg ligand 
 
 
Enantiomeric Ratio of 37c 
a 36:64 
b 36:64 
 
Run 20 
Ligand MW: 302.45 
3.0 mg ligand 
 
No conversion to 37c 
Run 21 
Ligand MW: 266.39 
2.7 mg ligand 
 
No conversion to 37c 
136 
 
 
Run 22 
Ligand MW: 512.25 
5.1 mg ligand 
 
No conversion to 37c 
Run 23 
Ligand MW: 610.76 
6.1 mg ligand 
 
No conversion to 37c 
Run 24 
Ligand MW: 458.56 
4.6 mg ligand 
 
 
No conversion to 37c 
Run 25 
Ligand MW: 452.47 
4.5 mg ligand 
 
No conversion to 37c 
Run 26 
Ligand MW: 330.39 
3.3 mg ligand 
 
No conversion to 37c 
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